Adipocyte - breast, donor1.CNhs11051.11376-118A8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte - breast, donor2.CNhs11969.11327-117E4 | 164.22 | 65.51 | 30.19 | 2.78 | 1.50 |
Adipocyte - omental, donor1.CNhs11054.11473-119C6 | 171.12 | 56.38 | 34.25 | 4.37 | 1.97 |
Adipocyte - omental, donor2.CNhs12067.11474-119C7 | 141.10 | 51.04 | 22.02 | 5.00 | 2.00 |
Adipocyte - omental, donor3.CNhs12068.11475-119C8 | 148.84 | 75.54 | 29.05 | 4.47 | 2.68 |
Adipocyte - perirenal, donor1.CNhs12069.11476-119C9 | 181.45 | 81.13 | 50.60 | 1.74 | 4.36 |
Adipocyte - subcutaneous, donor1.CNhs12494.11259-116F8 | 187.44 | 103.85 | 40.53 | 5.07 | 0.00 |
Adipocyte - subcutaneous, donor2.CNhs11371.11336-117F4 | 201.52 | 63.80 | 22.11 | 0.63 | 0.63 |
Adipocyte - subcutaneous, donor3.CNhs12017.11408-118E4 | 103.17 | 59.55 | 11.49 | 3.13 | 0.00 |
Alveolar Epithelial Cells, donor1.CNhs11325.11510-119G7 | 199.04 | 49.64 | 36.12 | 3.19 | 1.23 |
Alveolar Epithelial Cells, donor2.CNhs12084.11590-120G6 | 201.66 | 106.76 | 71.18 | 2.79 | 1.40 |
Amniotic Epithelial Cells, donor1.CNhs11341.11533-120A3 | 165.36 | 67.50 | 13.54 | 2.62 | 1.31 |
Amniotic Epithelial Cells, donor3.CNhs12125.11694-123A2 | 128.72 | 47.48 | 12.13 | 3.96 | 1.32 |
Anulus Pulposus Cell, donor1.CNhs10876.11248-116E6 | 97.53 | 43.07 | 4.46 | 9.78 | 0.12 |
Anulus Pulposus Cell, donor2.CNhs12064.11463-119B5 | 99.42 | 34.47 | 6.96 | 6.30 | 0.66 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1).CNhs13339.12642-134G5 | 155.31 | 118.33 | 45.72 | 6.72 | 2.69 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2).CNhs13358.12740-135I4 | 159.11 | 127.17 | 63.28 | 6.03 | 4.82 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31).CNhs13349.12652-134H6 | 158.48 | 105.89 | 40.17 | 7.30 | 5.84 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32).CNhs13369.12750-136A5 | 172.73 | 118.08 | 59.53 | 2.44 | 4.88 |
Astrocyte - cerebellum, donor1.CNhs11321.11500-119F6 | 92.22 | 38.66 | 10.96 | 5.05 | 1.11 |
Astrocyte - cerebellum, donor2.CNhs12081.11580-120F5 | 103.22 | 43.04 | 16.32 | 2.65 | 1.43 |
Astrocyte - cerebellum, donor3.CNhs12117.11661-122F5 | 92.47 | 28.84 | 10.97 | 1.88 | 0.63 |
Astrocyte - cerebral cortex, donor1.CNhs10864.11235-116D2 | 82.15 | 33.49 | 11.16 | 14.60 | 1.14 |
Astrocyte - cerebral cortex, donor2.CNhs11960.11316-117D2 | 77.74 | 32.71 | 11.50 | 10.27 | 0.55 |
Astrocyte - cerebral cortex, donor3.CNhs12005.11392-118C6 | 100.94 | 33.27 | 16.20 | 6.28 | 0.50 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1.CNhs12331.10821-111C2 | 64.03 | 39.66 | 8.02 | 19.26 | 0.31 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2.CNhs12332.10822-111C3 | 63.55 | 36.45 | 9.03 | 13.14 | 0.25 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3.CNhs12333.10823-111C4 | 68.16 | 34.95 | 7.48 | 19.60 | 0.39 |
Basophils, donor1.CNhs12546.12241-129G9 | 30.68 | 245.07 | 9.05 | 0.79 | 28.72 |
Basophils, donor2.CNhs12563.12242-129H1 | 49.51 | 163.90 | 9.60 | 3.84 | 13.82 |
Basophils, donor3.CNhs12575.12243-129H2 | 39.01 | 275.57 | 13.16 | 0.62 | 29.88 |
Bronchial Epithelial Cell, donor4.CNhs12054.11453-119A4 | 94.70 | 40.45 | 17.47 | 2.76 | 0.92 |
Bronchial Epithelial Cell, donor5.CNhs12058.11457-119A8 | 76.51 | 63.86 | 26.81 | 3.01 | 1.20 |
Bronchial Epithelial Cell, donor6.CNhs12062.11461-119B3 | 177.11 | 64.71 | 32.54 | 5.92 | 1.48 |
Burkitt's lymphoma cell line:DAUDI.CNhs10739.10422-106C8 | 45.86 | 262.54 | 13.87 | 9.76 | 6.12 |
Burkitt's lymphoma cell line:RAJI.CNhs11268.10476-106I8 | 60.71 | 180.84 | 13.36 | 9.53 | 2.99 |
CD133+ stem cells - adult bone marrow derived, pool1.CNhs12552.12224-129F1 | 41.98 | 289.20 | 7.34 | 7.63 | 11.45 |
CD14+ Monocytes, donor1.CNhs10852.11224-116B9 | 22.71 | 262.04 | 11.63 | 0.00 | 50.41 |
CD14+ Monocytes, donor2.CNhs11954.11305-117B9 | 26.47 | 209.37 | 9.02 | 0.60 | 26.67 |
CD14+ Monocytes, donor3.CNhs11997.11381-118B4 | 21.70 | 181.42 | 13.67 | 1.30 | 29.95 |
CD14+ monocyte derived endothelial progenitor cells, donor1.CNhs10858.11229-116C5 | 44.34 | 203.99 | 10.97 | 3.13 | 33.36 |
CD14+ monocyte derived endothelial progenitor cells, donor2.CNhs11897.11310-117C5 | 45.02 | 175.55 | 7.45 | 3.56 | 18.46 |
CD14+ monocyte derived endothelial progenitor cells, donor3.CNhs11904.11386-118B9 | 43.02 | 199.11 | 11.33 | 2.83 | 27.82 |
CD14+ monocytes - mock treated, donor1.CNhs13468.11863-125A9 | 19.77 | 231.62 | 12.36 | 0.15 | 49.29 |
CD14+ monocytes - mock treated, donor2.CNhs13484.11873-125C1 | 21.54 | 245.24 | 9.82 | 0.00 | 46.86 |
CD14+ monocytes - mock treated, donor3.CNhs13491.11883-125D2 | 18.68 | 205.23 | 11.40 | 0.73 | 54.82 |
CD14+ monocytes - treated with B-glucan, donor1.CNhs13474.11869-125B6 | 25.57 | 267.76 | 23.48 | 0.23 | 75.77 |
CD14+ monocytes - treated with B-glucan, donor2.CNhs13489.11879-125C7 | 18.09 | 274.66 | 24.67 | 0.82 | 63.73 |
CD14+ monocytes - treated with B-glucan, donor3.CNhs13495.11889-125D8 | 18.27 | 209.36 | 20.75 | 0.31 | 68.14 |
CD14+ monocytes - treated with BCG, donor1.CNhs13465.11860-125A6 | 24.45 | 269.57 | 27.91 | 0.00 | 50.35 |
CD14+ monocytes - treated with BCG, donor2.CNhs13475.11870-125B7 | 24.85 | 278.70 | 19.21 | 0.51 | 42.27 |
CD14+ monocytes - treated with BCG, donor3.CNhs13543.11880-125C8 | 23.88 | 269.59 | 15.84 | 0.47 | 57.70 |
CD14+ monocytes - treated with Candida, donor1.CNhs13473.11868-125B5 | 18.62 | 309.93 | 31.37 | 0.00 | 60.68 |
CD14+ monocytes - treated with Candida, donor2.CNhs13488.11878-125C6 | 17.43 | 299.50 | 21.95 | 0.65 | 71.00 |
CD14+ monocytes - treated with Candida, donor3.CNhs13494.11888-125D7 | 21.67 | 228.87 | 32.50 | 0.00 | 78.55 |
CD14+ monocytes - treated with Cryptococcus, donor1.CNhs13472.11867-125B4 | 20.52 | 278.79 | 19.77 | 0.19 | 75.86 |
CD14+ monocytes - treated with Cryptococcus, donor2.CNhs13487.11877-125C5 | 24.29 | 249.98 | 15.56 | 0.55 | 69.05 |
CD14+ monocytes - treated with Cryptococcus, donor3.CNhs13546.11887-125D6 | 22.92 | 234.39 | 16.40 | 0.22 | 123.60 |
CD14+ monocytes - treated with Group A streptococci, donor1.CNhs13469.11864-125B1 | 23.57 | 313.74 | 39.18 | 0.00 | 114.48 |
CD14+ monocytes - treated with Group A streptococci, donor2.CNhs13532.11874-125C2 | 23.43 | 367.46 | 30.17 | 0.32 | 109.44 |
CD14+ monocytes - treated with Group A streptococci, donor3.CNhs13492.11884-125D3 | 33.88 | 240.39 | 37.72 | 0.00 | 120.20 |
CD14+ monocytes - treated with IFN + N-hexane, donor1.CNhs13466.11861-125A7 | 28.70 | 220.67 | 13.19 | 0.33 | 45.52 |
CD14+ monocytes - treated with IFN + N-hexane, donor2.CNhs13476.11871-125B8 | 22.54 | 286.43 | 16.16 | 0.00 | 41.29 |
CD14+ monocytes - treated with IFN + N-hexane, donor3.CNhs13490.11881-125C9 | 23.87 | 192.65 | 12.79 | 0.85 | 49.44 |
CD14+ monocytes - treated with Salmonella, donor1.CNhs13471.11866-125B3 | 29.02 | 335.48 | 33.66 | 0.00 | 89.96 |
CD14+ monocytes - treated with Salmonella, donor2.CNhs13485.11876-125C4 | 23.26 | 292.20 | 24.96 | 0.00 | 82.84 |
CD14+ monocytes - treated with Salmonella, donor3.CNhs13493.11886-125D5 | 21.18 | 254.73 | 28.03 | 0.00 | 120.83 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1.CNhs13467.11862-125A8 | 17.84 | 240.70 | 19.85 | 0.25 | 32.91 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2.CNhs13483.11872-125B9 | 20.86 | 260.22 | 20.86 | 0.00 | 37.03 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3.CNhs13544.11882-125D1 | 19.98 | 263.23 | 16.29 | 0.00 | 48.43 |
CD14+ monocytes - treated with lipopolysaccharide, donor1.CNhs13470.11865-125B2 | 29.06 | 268.80 | 24.82 | 1.82 | 61.15 |
CD14+ monocytes - treated with lipopolysaccharide, donor2.CNhs13533.11875-125C3 | 22.10 | 329.98 | 30.20 | 0.37 | 87.65 |
CD14+ monocytes - treated with lipopolysaccharide, donor3.CNhs13545.11885-125D4 | 24.05 | 306.02 | 32.28 | 0.32 | 130.38 |
CD14+CD16+ Monocytes, donor1.CNhs13541.11789-124B7 | 28.94 | 296.60 | 6.13 | 0.63 | 21.76 |
CD14+CD16+ Monocytes, donor2.CNhs13208.11801-124D1 | 22.96 | 285.10 | 8.72 | 0.85 | 23.17 |
CD14+CD16+ Monocytes, donor3.CNhs13549.11912-125G4 | 29.14 | 283.04 | 7.55 | 0.21 | 24.11 |
CD14+CD16- Monocytes, donor1.CNhs13224.11788-124B6 | 25.05 | 308.68 | 7.98 | 0.90 | 31.00 |
CD14+CD16- Monocytes, donor2.CNhs13216.11799-124C8 | 29.89 | 280.98 | 5.86 | 0.90 | 27.63 |
CD14+CD16- Monocytes, donor3.CNhs13540.11910-125G2 | 21.06 | 277.09 | 4.50 | 0.80 | 26.84 |
CD14-CD16+ Monocytes, donor1.CNhs13229.11790-124B8 | 35.34 | 415.26 | 13.40 | 1.14 | 30.78 |
CD14-CD16+ Monocytes, donor2.CNhs13207.11800-124C9 | 30.04 | 331.00 | 6.37 | 0.60 | 21.68 |
CD14-CD16+ Monocytes, donor3.CNhs13548.11911-125G3 | 26.85 | 311.63 | 10.78 | 1.10 | 20.64 |
CD19+ B Cells (pluriselect), donor090309, donation1.CNhs12177.12189-129B2 | 66.88 | 330.87 | 0.00 | 10.56 | 7.04 |
CD19+ B Cells (pluriselect), donor090309, donation2.CNhs12179.12194-129B7 | 54.61 | 240.30 | 7.65 | 7.65 | 2.18 |
CD19+ B Cells (pluriselect), donor090309, donation3.CNhs12181.12199-129C3 | 47.14 | 276.64 | 6.23 | 12.45 | 2.67 |
CD19+ B Cells (pluriselect), donor090325, donation1.CNhs12531.12151-128F9 | 56.33 | 299.14 | 9.81 | 6.40 | 8.53 |
CD19+ B Cells (pluriselect), donor090325, donation2.CNhs12175.12174-128I5 | 38.44 | 263.86 | 2.00 | 9.61 | 1.60 |
CD19+ B Cells (pluriselect), donor090612, donation1.CNhs12183.12204-129C8 | 41.96 | 241.40 | 6.32 | 8.62 | 2.87 |
CD19+ B Cells (pluriselect), donor090612, donation2.CNhs12185.12209-129D4 | 39.00 | 247.23 | 8.59 | 12.56 | 3.31 |
CD19+ B Cells (pluriselect), donor090612, donation3.CNhs12188.12214-129D9 | 61.06 | 268.09 | 4.77 | 7.63 | 1.91 |
CD19+ B Cells, donor1.CNhs12343.11544-120B5 | 21.63 | 176.46 | 6.83 | 1.14 | 5.12 |
CD19+ B Cells, donor2.CNhs12352.11624-122B4 | 37.00 | 211.99 | 5.87 | 2.94 | 3.52 |
CD19+ B Cells, donor3.CNhs12354.11705-123B4 | 29.82 | 185.40 | 6.88 | 5.73 | 5.73 |
CD34+ Progenitors, donor1.CNhs13227.11545-120B6 | 33.04 | 296.06 | 5.29 | 2.64 | 13.22 |
CD34+ Progenitors, donor2.CNhs12205.11625-122B5 | 25.22 | 223.64 | 14.57 | 4.48 | 14.01 |
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1.CNhs12588.12225-129F2 | 55.57 | 217.03 | 10.27 | 4.48 | 6.58 |
CD4+ T Cells, donor1.CNhs10853.11225-116C1 | 69.83 | 156.38 | 16.13 | 2.36 | 0.20 |
CD4+ T Cells, donor2.CNhs11955.11306-117C1 | 71.13 | 167.03 | 15.72 | 2.36 | 1.57 |
CD4+ T Cells, donor3.CNhs11998.11382-118B5 | 70.52 | 169.83 | 21.59 | 2.88 | 3.08 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1.CNhs13203.11793-124C2 | 82.26 | 93.12 | 6.02 | 7.36 | 0.00 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor1.CNhs13238.11780-124A7 | 107.55 | 179.26 | 18.25 | 3.59 | 0.33 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor2.CNhs13235.11796-124C5 | 97.06 | 214.00 | 8.52 | 3.31 | 0.47 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor3.CNhs13513.11907-125F8 | 105.21 | 183.14 | 5.84 | 1.95 | 0.00 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1.CNhs13204.11794-124C3 | 116.98 | 148.06 | 17.27 | 10.81 | 0.67 |
CD4+CD25+CD45RA- memory regulatory T cells, donor1.CNhs13195.11782-124A9 | 105.17 | 120.20 | 10.90 | 4.71 | 1.47 |
CD4+CD25+CD45RA- memory regulatory T cells, donor2.CNhs13206.11797-124C6 | 107.89 | 126.27 | 8.86 | 4.87 | 0.00 |
CD4+CD25+CD45RA- memory regulatory T cells, donor3.CNhs13538.11908-125F9 | 87.20 | 93.16 | 7.31 | 7.58 | 0.54 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2.CNhs13811.11916-125G8 | 101.83 | 86.59 | 11.40 | 7.30 | 0.00 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3.CNhs13812.11920-125H3 | 98.72 | 85.06 | 12.49 | 7.41 | 0.39 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2.CNhs13813.11913-125G5 | 85.67 | 153.26 | 10.20 | 8.06 | 0.49 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3.CNhs13814.11917-125G9 | 98.10 | 133.75 | 9.67 | 9.12 | 0.83 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1.CNhs13202.11791-124B9 | 73.03 | 86.94 | 4.06 | 6.38 | 0.58 |
CD4+CD25-CD45RA+ naive conventional T cells, donor1.CNhs13223.11784-124B2 | 74.88 | 208.79 | 10.38 | 5.04 | 0.15 |
CD4+CD25-CD45RA+ naive conventional T cells, donor2.CNhs13205.11795-124C4 | 81.87 | 197.45 | 8.56 | 6.15 | 0.00 |
CD4+CD25-CD45RA+ naive conventional T cells, donor3.CNhs13512.11906-125F7 | 75.27 | 182.94 | 8.36 | 3.14 | 1.05 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1.CNhs13215.11792-124C1 | 81.36 | 109.68 | 7.37 | 9.29 | 0.11 |
CD4+CD25-CD45RA- memory conventional T cells, donor1.CNhs13239.11786-124B4 | 85.46 | 175.90 | 13.03 | 4.60 | 1.92 |
CD4+CD25-CD45RA- memory conventional T cells, donor2.CNhs13237.11798-124C7 | 98.96 | 177.66 | 15.81 | 6.87 | 1.03 |
CD4+CD25-CD45RA- memory conventional T cells, donor3.CNhs13539.11909-125G1 | 75.91 | 137.90 | 9.11 | 4.30 | 0.25 |
CD8+ T Cells (pluriselect), donor090309, donation1.CNhs12176.12186-129A8 | 85.38 | 177.12 | 7.01 | 5.42 | 0.96 |
CD8+ T Cells (pluriselect), donor090309, donation2.CNhs12178.12191-129B4 | 72.92 | 178.40 | 7.81 | 3.91 | 0.00 |
CD8+ T Cells (pluriselect), donor090309, donation3.CNhs12180.12196-129B9 | 113.10 | 191.99 | 15.21 | 4.75 | 0.95 |
CD8+ T Cells (pluriselect), donor090325, donation1.CNhs12201.12148-128F6 | 61.74 | 149.67 | 4.07 | 3.61 | 2.26 |
CD8+ T Cells (pluriselect), donor090325, donation2.CNhs12199.12171-128I2 | 69.62 | 148.08 | 5.25 | 8.06 | 0.90 |
CD8+ T Cells (pluriselect), donor090612, donation1.CNhs12182.12201-129C5 | 83.70 | 123.68 | 7.50 | 6.25 | 3.75 |
CD8+ T Cells (pluriselect), donor090612, donation2.CNhs12184.12206-129D1 | 75.53 | 153.91 | 6.39 | 7.58 | 3.08 |
CD8+ T Cells (pluriselect), donor090612, donation3.CNhs12187.12211-129D6 | 90.32 | 152.73 | 7.39 | 4.93 | 0.82 |
CD8+ T Cells, donor1.CNhs10854.11226-116C2 | 82.86 | 148.18 | 25.20 | 3.63 | 3.02 |
CD8+ T Cells, donor2.CNhs11956.11307-117C2 | 66.86 | 100.56 | 22.20 | 2.67 | 1.87 |
CD8+ T Cells, donor3.CNhs11999.11383-118B6 | 68.65 | 116.44 | 17.23 | 2.32 | 0.58 |
Cardiac Myocyte, donor1.CNhs12341.11525-119I4 | 102.40 | 46.32 | 14.63 | 7.31 | 0.00 |
Cardiac Myocyte, donor2.CNhs12350.11605-120I3 | 130.79 | 59.69 | 14.08 | 2.68 | 0.67 |
Cardiac Myocyte, donor3.CNhs12571.11686-122I3 | 157.91 | 82.85 | 16.11 | 0.77 | 0.90 |
Chondrocyte - de diff, donor1.CNhs11923.11261-116G1 | 150.00 | 62.17 | 28.92 | 3.61 | 0.72 |
Chondrocyte - de diff, donor2.CNhs11372.11338-117F6 | 87.23 | 39.61 | 11.53 | 1.50 | 1.50 |
Chondrocyte - de diff, donor3.CNhs12020.11410-118E6 | 117.91 | 78.80 | 15.06 | 3.33 | 1.45 |
Chondrocyte - re diff, donor2.CNhs11373.11339-117F7 | 159.06 | 38.97 | 14.32 | 1.59 | 0.80 |
Chondrocyte - re diff, donor3.CNhs12021.11411-118E7 | 206.82 | 104.14 | 26.76 | 1.95 | 3.89 |
Ciliary Epithelial Cells, donor1.CNhs10871.11242-116D9 | 76.20 | 35.17 | 7.85 | 8.13 | 1.32 |
Ciliary Epithelial Cells, donor2.CNhs11966.11323-117D9 | 112.20 | 41.69 | 19.29 | 5.54 | 0.67 |
Ciliary Epithelial Cells, donor3.CNhs12009.11399-118D4 | 118.93 | 45.85 | 13.53 | 3.78 | 1.67 |
Clontech Human Universal Reference Total RNA, pool1.CNhs10608.10000-101A1 | 71.97 | 36.35 | 11.53 | 5.76 | 3.34 |
Corneal Epithelial Cells, donor1.CNhs11336.11526-119I5 | 154.83 | 95.08 | 13.11 | 1.82 | 1.46 |
Corneal Epithelial Cells, donor3.CNhs12123.11687-122I4 | 114.94 | 59.70 | 11.49 | 2.97 | 1.11 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep1.CNhs10855.11227-116C3 | 70.75 | 221.99 | 25.64 | 4.87 | 31.81 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep2.CNhs11062.11227-116C3 | 70.70 | 222.71 | 32.04 | 4.88 | 40.40 |
Dendritic Cells - monocyte immature derived, donor3.CNhs12000.11384-118B7 | 63.95 | 159.68 | 25.93 | 3.32 | 27.39 |
Dendritic Cells - plasmacytoid, donor1.CNhs10857.11228-116C4 | 32.91 | 279.51 | 7.39 | 3.10 | 10.97 |
Dendritic Cells - plasmacytoid, donor2.CNhs12196.11309-117C4 | 30.89 | 303.16 | 9.15 | 4.00 | 10.30 |
Dendritic Cells - plasmacytoid, donor3.CNhs12200.11385-118B8 | 22.66 | 241.45 | 10.77 | 3.71 | 8.17 |
Endothelial Cells - Aortic, donor0.CNhs10837.11207-116A1 | 66.98 | 122.44 | 17.69 | 2.58 | 4.57 |
Endothelial Cells - Aortic, donor1.CNhs12495.11263-116G3 | 86.02 | 92.91 | 15.48 | 1.72 | 4.30 |
Endothelial Cells - Aortic, donor2.CNhs11375.11340-117F8 | 99.28 | 115.94 | 18.75 | 2.08 | 2.43 |
Endothelial Cells - Aortic, donor3.CNhs12022.11412-118E8 | 66.71 | 89.88 | 10.74 | 1.70 | 5.65 |
Endothelial Cells - Artery, donor1.CNhs12496.11264-116G4 | 84.32 | 106.55 | 20.97 | 0.84 | 10.07 |
Endothelial Cells - Artery, donor2.CNhs11977.11341-117F9 | 86.11 | 127.65 | 24.49 | 0.28 | 6.88 |
Endothelial Cells - Artery, donor3.CNhs12023.11413-118E9 | 85.48 | 104.92 | 23.41 | 1.25 | 4.39 |
Endothelial Cells - Lymphatic, donor1.CNhs10865.11236-116D3 | 70.03 | 90.96 | 6.98 | 2.84 | 2.07 |
Endothelial Cells - Lymphatic, donor2.CNhs11901.11317-117D3 | 87.52 | 81.47 | 9.96 | 1.78 | 4.27 |
Endothelial Cells - Lymphatic, donor3.CNhs11906.11393-118C7 | 81.34 | 80.00 | 7.36 | 1.00 | 3.01 |
Endothelial Cells - Microvascular, donor1.CNhs11925.11265-116G5 | 47.53 | 93.05 | 9.27 | 2.01 | 2.42 |
Endothelial Cells - Microvascular, donor2.CNhs11376.11342-117G1 | 98.84 | 103.40 | 9.88 | 1.52 | 3.80 |
Endothelial Cells - Microvascular, donor3.CNhs12024.11414-118F1 | 45.40 | 118.37 | 2.20 | 2.20 | 3.90 |
Endothelial Cells - Thoracic, donor1.CNhs11926.11266-116G6 | 76.11 | 105.52 | 21.32 | 1.10 | 2.21 |
Endothelial Cells - Thoracic, donor2.CNhs11978.11343-117G2 | 116.66 | 122.33 | 17.01 | 0.00 | 7.29 |
Endothelial Cells - Umbilical vein, donor1.CNhs10872.11243-116E1 | 61.26 | 95.73 | 7.41 | 3.75 | 2.32 |
Endothelial Cells - Umbilical vein, donor2.CNhs11967.11324-117E1 | 57.48 | 97.67 | 8.31 | 2.92 | 2.47 |
Endothelial Cells - Umbilical vein, donor3.CNhs12010.11400-118D5 | 72.18 | 98.87 | 9.80 | 1.91 | 2.82 |
Endothelial Cells - Vein, donor1.CNhs12497.11267-116G7 | 72.06 | 67.46 | 23.00 | 0.00 | 4.60 |
Endothelial Cells - Vein, donor2.CNhs11377.11344-117G3 | 93.03 | 140.49 | 18.99 | 0.00 | 5.70 |
Endothelial Cells - Vein, donor3.CNhs12026.11416-118F3 | 76.40 | 103.33 | 13.92 | 0.37 | 4.58 |
Eosinophils, donor2.CNhs12548.12245-129H4 | 27.67 | 284.65 | 15.81 | 0.00 | 283.33 |
Eosinophils, donor3.CNhs12549.12246-129H5 | 50.41 | 403.29 | 23.27 | 0.00 | 252.06 |
Esophageal Epithelial Cells, donor1.CNhs11323.11507-119G4 | 155.69 | 114.69 | 15.26 | 3.92 | 1.74 |
Ewing's sarcoma cell line:Hs 863.T.CNhs11836.10705-109H3 | 164.50 | 76.04 | 30.32 | 0.00 | 5.96 |
Fibroblast - Aortic Adventitial, donor1.CNhs10874.11245-116E3 | 148.41 | 68.76 | 30.14 | 1.77 | 2.66 |
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction).CNhs12581.14332-155F3 | 96.00 | 27.28 | 33.10 | 7.55 | 5.96 |
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction).CNhs12400.14311-155C9 | 69.41 | 14.05 | 23.52 | 9.18 | 0.57 |
Fibroblast - Aortic Adventitial, donor3.CNhs12011.11401-118D6 | 138.32 | 51.07 | 29.44 | 1.77 | 2.13 |
Fibroblast - Cardiac, donor1.CNhs12498.11268-116G8 | 117.74 | 63.36 | 30.84 | 1.68 | 1.68 |
Fibroblast - Cardiac, donor2.CNhs11378.11345-117G4 | 200.69 | 149.45 | 62.98 | 1.07 | 2.13 |
Fibroblast - Cardiac, donor3.CNhs12027.11417-118F4 | 164.53 | 92.25 | 40.95 | 2.47 | 4.19 |
Fibroblast - Cardiac, donor4.CNhs11909.11452-119A3 | 124.48 | 57.57 | 15.56 | 3.42 | 1.24 |
Fibroblast - Cardiac, donor5.CNhs12057.11456-119A7 | 109.52 | 78.27 | 20.75 | 2.16 | 1.08 |
Fibroblast - Cardiac, donor6.CNhs12061.11460-119B2 | 99.55 | 62.77 | 20.27 | 1.80 | 1.63 |
Fibroblast - Choroid Plexus, donor1.CNhs11319.11492-119E7 | 198.58 | 77.80 | 28.15 | 1.66 | 1.51 |
Fibroblast - Choroid Plexus, donor2.CNhs12344.11572-120E6 | 228.74 | 86.43 | 33.42 | 0.58 | 0.58 |
Fibroblast - Conjunctival, donor1.CNhs11339.11531-120A1 | 220.03 | 62.56 | 18.28 | 3.98 | 0.70 |
Fibroblast - Dermal, donor1.CNhs12499.11269-116G9 | 147.03 | 56.19 | 20.60 | 1.25 | 1.25 |
Fibroblast - Dermal, donor2.CNhs11379.11346-117G5 | 135.77 | 58.76 | 21.11 | 0.00 | 1.14 |
Fibroblast - Dermal, donor3.CNhs12028.11418-118F5 | 147.21 | 77.12 | 16.14 | 1.20 | 1.79 |
Fibroblast - Dermal, donor4.CNhs12052.11450-119A1 | 145.97 | 45.09 | 17.15 | 4.70 | 0.23 |
Fibroblast - Dermal, donor5.CNhs12055.11454-119A5 | 137.75 | 47.91 | 19.10 | 3.40 | 0.81 |
Fibroblast - Dermal, donor6.CNhs12059.11458-119A9 | 154.36 | 39.75 | 24.30 | 2.39 | 0.42 |
Fibroblast - Gingival, donor1.CNhs10866.11237-116D4 | 139.85 | 48.79 | 15.52 | 4.90 | 1.02 |
Fibroblast - Gingival, donor2.CNhs11961.11318-117D4 | 153.17 | 45.20 | 15.48 | 4.42 | 0.37 |
Fibroblast - Gingival, donor3.CNhs12006.11394-118C8 | 117.27 | 52.70 | 8.99 | 5.58 | 0.21 |
Fibroblast - Gingival, donor4 (GFH2).CNhs10848.11222-116B7 | 140.18 | 46.33 | 22.57 | 3.56 | 0.00 |
Fibroblast - Gingival, donor5 (GFH3).CNhs11952.11303-117B7 | 169.63 | 64.78 | 23.74 | 2.97 | 0.74 |
Fibroblast - Lymphatic, donor1.CNhs11322.11506-119G3 | 253.94 | 70.08 | 33.68 | 0.91 | 0.91 |
Fibroblast - Lymphatic, donor3.CNhs12118.11667-122G2 | 252.95 | 106.36 | 29.46 | 1.44 | 1.44 |
Fibroblast - Periodontal Ligament, donor1.CNhs10867.11238-116D5 | 176.75 | 53.53 | 18.01 | 3.70 | 0.17 |
Fibroblast - Periodontal Ligament, donor2.CNhs11962.11319-117D5 | 141.01 | 40.04 | 13.89 | 3.13 | 0.13 |
Fibroblast - Periodontal Ligament, donor3.CNhs11907.11395-118C9 | 147.68 | 42.94 | 19.12 | 1.94 | 1.66 |
Fibroblast - Periodontal Ligament, donor4 (PL29).CNhs12493.11223-116B8 | 146.18 | 43.02 | 14.05 | 0.88 | 0.44 |
Fibroblast - Periodontal Ligament, donor5 (PL30).CNhs11953.11304-117B8 | 153.86 | 49.65 | 24.21 | 2.15 | 1.84 |
Fibroblast - Periodontal Ligament, donor6 (PLH3).CNhs11996.11380-118B3 | 141.07 | 70.46 | 19.08 | 1.50 | 1.35 |
Fibroblast - Pulmonary Artery, donor1.CNhs10878.11250-116E8 | 180.02 | 78.84 | 35.16 | 0.57 | 2.72 |
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction).CNhs12405.14329-155E9 | 80.55 | 19.73 | 17.40 | 1.08 | 0.00 |
Fibroblast - skin dystrophia myotonica, donor1.CNhs11353.11556-120C8 | 171.91 | 68.77 | 17.94 | 4.06 | 0.85 |
Fibroblast - skin dystrophia myotonica, donor2.CNhs11354.11557-120C9 | 152.17 | 78.63 | 19.29 | 3.18 | 0.42 |
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction).CNhs12399.14308-155C6 | 81.02 | 24.01 | 21.61 | 1.50 | 0.60 |
Fibroblast - skin dystrophia myotonica, donor3.CNhs11913.11560-120D3 | 113.67 | 57.61 | 25.66 | 3.40 | 1.03 |
Fibroblast - skin normal, donor1 (nuclear fraction).CNhs12403.14323-155E3 | 96.36 | 20.10 | 15.46 | 2.32 | 1.29 |
Fibroblast - skin normal, donor1.CNhs11351.11553-120C5 | 163.78 | 56.39 | 13.96 | 2.61 | 1.30 |
Fibroblast - skin normal, donor2 (nuclear fraction).CNhs12582.14302-155B9 | 75.78 | 16.03 | 12.49 | 2.19 | 0.17 |
Fibroblast - skin normal, donor2.CNhs11914.11561-120D4 | 124.52 | 44.33 | 21.14 | 2.05 | 1.27 |
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction).CNhs12404.14326-155E6 | 86.08 | 15.40 | 13.63 | 4.54 | 0.25 |
Fibroblast - skin spinal muscular atrophy, donor1.CNhs11074.11555-120C7 | 154.83 | 77.14 | 16.20 | 3.59 | 0.83 |
Fibroblast - skin spinal muscular atrophy, donor2.CNhs11911.11558-120D1 | 110.57 | 62.88 | 11.96 | 8.24 | 0.16 |
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction).CNhs12398.14305-155C3 | 102.95 | 26.27 | 18.46 | 4.62 | 1.42 |
Fibroblast - skin spinal muscular atrophy, donor3.CNhs11912.11559-120D2 | 127.25 | 44.03 | 23.98 | 2.62 | 1.91 |
Fibroblast - skin walker warburg, donor1.CNhs11352.11554-120C6 | 145.31 | 39.68 | 15.94 | 3.56 | 0.68 |
Gingival epithelial cells, donor1 (GEA11).CNhs11061.11221-116B6 | 125.43 | 81.36 | 40.78 | 5.22 | 4.83 |
Gingival epithelial cells, donor2 (GEA14).CNhs11896.11302-117B6 | 141.28 | 77.19 | 38.46 | 4.91 | 5.73 |
Gingival epithelial cells, donor3 (GEA15).CNhs11903.11379-118B2 | 99.81 | 47.04 | 35.28 | 3.73 | 3.15 |
H9 Embryonic Stem cells, biol_rep2 (H9ES-2).CNhs12824.12724-135G6 | 114.17 | 57.45 | 15.49 | 4.64 | 1.22 |
H9 Embryonic Stem cells, biol_rep3 (H9ES-3).CNhs12837.12822-136I5 | 105.76 | 55.26 | 14.71 | 6.89 | 1.19 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0).CNhs12822.12627-134E8 | 118.17 | 62.51 | 17.31 | 6.86 | 1.39 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0).CNhs12825.12725-135G7 | 111.95 | 67.07 | 17.83 | 5.91 | 1.76 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0).CNhs12908.12823-136I6 | 106.73 | 51.22 | 16.65 | 3.53 | 1.26 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3).CNhs13738.13366-143F9 | 107.30 | 47.08 | 16.42 | 12.41 | 0.73 |
Hair Follicle Dermal Papilla Cells, donor1.CNhs12501.11271-116H2 | 168.97 | 54.76 | 40.68 | 1.56 | 0.00 |
Hair Follicle Dermal Papilla Cells, donor2.CNhs11979.11348-117G7 | 174.96 | 75.26 | 26.37 | 1.93 | 1.29 |
Hair Follicle Dermal Papilla Cells, donor3.CNhs12030.11420-118F7 | 200.30 | 59.40 | 33.15 | 0.00 | 2.76 |
Hair Follicle Outer Root Sheath Cells, donor1.CNhs12339.11504-119G1 | 123.06 | 75.69 | 13.93 | 6.04 | 0.46 |
Hair Follicle Outer Root Sheath Cells, donor2.CNhs12347.11584-120F9 | 118.39 | 72.19 | 15.88 | 2.89 | 2.89 |
Hep-2 cells mock treated, biol_rep1.CNhs13479.11898-125E8 | 70.87 | 49.22 | 15.14 | 2.60 | 1.30 |
Hep-2 cells mock treated, biol_rep2.CNhs13500.11899-125E9 | 64.23 | 48.05 | 17.03 | 2.36 | 1.69 |
Hep-2 cells mock treated, biol_rep3.CNhs13501.11900-125F1 | 70.86 | 46.27 | 19.28 | 2.17 | 1.21 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep1.CNhs13477.11890-125D9 | 71.91 | 49.96 | 18.86 | 2.43 | 1.76 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep2.CNhs13496.11891-125E1 | 69.07 | 40.09 | 14.16 | 2.83 | 0.87 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep3.CNhs13497.11892-125E2 | 66.67 | 50.30 | 17.08 | 2.61 | 1.66 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1.CNhs13478.11894-125E4 | 74.43 | 58.92 | 23.33 | 2.56 | 2.16 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2.CNhs13498.11895-125E5 | 67.89 | 51.80 | 19.82 | 1.96 | 0.78 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3.CNhs13499.11896-125E6 | 65.02 | 58.87 | 23.47 | 2.31 | 1.15 |
Hepatic Sinusoidal Endothelial Cells, donor1.CNhs12075.11521-119H9 | 62.01 | 70.86 | 7.38 | 0.00 | 1.48 |
Hepatic Sinusoidal Endothelial Cells, donor2.CNhs12092.11601-120H8 | 180.91 | 152.86 | 26.65 | 0.00 | 1.40 |
Hepatic Stellate Cells (lipocyte), donor1.CNhs11335.11524-119I3 | 211.55 | 67.50 | 22.64 | 1.65 | 1.23 |
Hepatic Stellate Cells (lipocyte), donor2.CNhs12093.11604-120I2 | 219.04 | 116.14 | 20.58 | 1.47 | 4.41 |
Hepatocyte, donor1.CNhs12340.11523-119I2 | 282.66 | 95.07 | 54.50 | 6.34 | 1.27 |
Hepatocyte, donor2.CNhs12349.11603-120I1 | 181.82 | 82.56 | 41.28 | 3.93 | 3.93 |
Hepatocyte, donor3.CNhs12626.11684-122I1 | 203.82 | 62.03 | 50.81 | 5.32 | 4.14 |
Hodgkin's lymphoma cell line:HD-Mar2.CNhs11715.10435-106E3 | 89.18 | 65.34 | 23.40 | 11.92 | 3.53 |
Intestinal epithelial cells (polarized), donor1.CNhs10875.11246-116E4 | 103.31 | 64.69 | 20.66 | 9.22 | 3.94 |
Iris Pigment Epithelial Cells, donor1.CNhs12596.11530-119I9 | 130.05 | 52.33 | 17.67 | 2.75 | 1.54 |
Keratinocyte - epidermal, donor1.CNhs11064.11272-116H3 | 122.15 | 53.78 | 23.71 | 4.61 | 1.43 |
Keratinocyte - epidermal, donor2.CNhs11381.11349-117G8 | 196.70 | 77.56 | 30.35 | 1.12 | 0.00 |
Keratinocyte - epidermal, donor3.CNhs12031.11421-118F8 | 172.41 | 67.96 | 29.05 | 3.32 | 1.01 |
Keratinocyte - oral, donor1.CNhs10879.11251-116E9 | 120.46 | 75.00 | 8.70 | 5.65 | 0.65 |
Keratocytes, donor1.CNhs11337.11527-119I6 | 344.38 | 74.94 | 29.32 | 0.98 | 0.98 |
Keratocytes, donor2.CNhs12095.11607-120I5 | 201.75 | 59.28 | 21.84 | 1.04 | 0.00 |
Lens Epithelial Cells, donor1.CNhs12342.11529-119I8 | 131.34 | 59.18 | 20.21 | 2.89 | 2.89 |
Lens Epithelial Cells, donor2.CNhs12568.11609-120I7 | 66.31 | 29.68 | 4.52 | 4.99 | 0.12 |
Lens Epithelial Cells, donor3.CNhs12572.11690-122I7 | 187.97 | 78.55 | 31.82 | 4.34 | 3.64 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1).CNhs11936.12260-130A1 | 58.47 | 82.58 | 8.95 | 2.31 | 2.31 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1).CNhs13157.12382-131E6 | 49.54 | 116.67 | 6.94 | 1.85 | 2.31 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ).CNhs13276.12504-133A2 | 57.08 | 84.09 | 7.42 | 4.19 | 2.09 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2.CNhs12475.13097-140D1 | 143.82 | 76.65 | 31.61 | 3.95 | 3.95 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3.CNhs12703.13163-141B4 | 145.08 | 80.70 | 28.33 | 6.87 | 2.58 |
Macrophage - monocyte derived, donor1.CNhs10861.11232-116C8 | 53.68 | 130.99 | 7.39 | 1.23 | 24.13 |
Macrophage - monocyte derived, donor2.CNhs11899.11313-117C8 | 72.78 | 101.56 | 7.49 | 2.11 | 12.40 |
Macrophage - monocyte derived, donor3.CNhs12003.11389-118C3 | 54.70 | 135.25 | 11.59 | 1.04 | 18.28 |
Mallassez-derived cells, donor1 (MZH3).CNhs12538.12142-128E9 | 174.34 | 87.17 | 56.24 | 4.69 | 11.25 |
Mallassez-derived cells, donor2.CNhs13550.11929-125I3 | 155.38 | 54.26 | 28.89 | 5.88 | 5.04 |
Mallassez-derived cells, donor3.CNhs13551.11930-125I4 | 137.81 | 57.99 | 27.79 | 4.96 | 1.84 |
Mammary Epithelial Cell, donor1.CNhs11077.11273-116H4 | 147.06 | 83.56 | 28.48 | 3.40 | 1.79 |
Mammary Epithelial Cell, donor2.CNhs11382.11350-117G9 | 121.48 | 70.33 | 12.79 | 6.68 | 2.62 |
Mammary Epithelial Cell, donor3.CNhs12032.11422-118F9 | 54.44 | 41.79 | 11.50 | 0.77 | 0.77 |
Mast cell - stimulated, donor1.CNhs11073.11487-119E2 | 191.15 | 215.79 | 66.02 | 11.82 | 8.87 |
Mast cell, donor1.CNhs12566.11563-120D6 | 55.65 | 128.99 | 10.13 | 8.01 | 2.38 |
Mast cell, donor2.CNhs12594.11565-120D8 | 49.14 | 160.06 | 8.92 | 2.28 | 3.32 |
Mast cell, donor3.CNhs12593.11566-120D9 | 62.69 | 105.64 | 8.07 | 1.59 | 2.45 |
Mast cell, donor4.CNhs12592.11567-120E1 | 52.52 | 158.94 | 11.87 | 1.26 | 4.29 |
Melanocyte - dark, donor3.CNhs12570.11663-122F7 | 62.35 | 22.99 | 6.10 | 1.46 | 0.70 |
Melanocyte - light, donor1.CNhs11303.11274-116H5 | 90.91 | 47.75 | 8.40 | 0.38 | 1.15 |
Melanocyte - light, donor2.CNhs11383.11351-117H1 | 55.09 | 32.82 | 7.03 | 2.34 | 0.00 |
Melanocyte - light, donor3.CNhs12033.11423-118G1 | 63.30 | 46.19 | 3.42 | 0.00 | 1.71 |
Melanocyte, donor1 (MC+1).CNhs12816.12641-134G4 | 88.12 | 35.68 | 11.31 | 2.16 | 0.41 |
Melanocyte, donor2 (MC+2).CNhs13156.12739-135I3 | 85.90 | 52.26 | 8.71 | 3.00 | 0.30 |
Melanocyte, donor3 (MC+3).CNhs13406.12837-137B2 | 69.46 | 31.44 | 4.86 | 1.71 | 0.00 |
Meningeal Cells, donor1.CNhs11320.11493-119E8 | 128.95 | 64.36 | 19.74 | 1.23 | 0.56 |
Meningeal Cells, donor2.CNhs12080.11573-120E7 | 154.33 | 52.32 | 24.85 | 0.87 | 1.31 |
Meningeal Cells, donor3.CNhs12731.11654-122E7 | 144.18 | 56.98 | 18.04 | 2.49 | 0.51 |
Mesenchymal Stem Cells - Wharton's Jelly, donor1.CNhs11057.11548-120B9 | 175.55 | 102.38 | 38.14 | 1.29 | 5.17 |
Mesenchymal Stem Cells - adipose, donor1.CNhs11345.11537-120A7 | 175.25 | 346.93 | 17.88 | 0.00 | 3.58 |
Mesenchymal Stem Cells - adipose, donor3.CNhs12922.11698-123A6 | 241.76 | 67.62 | 37.19 | 2.54 | 0.85 |
Mesenchymal Stem Cells - amniotic membrane, donor1.CNhs11349.11547-120B8 | 156.64 | 47.34 | 11.17 | 3.99 | 1.06 |
Mesenchymal Stem Cells - amniotic membrane, donor2.CNhs12104.11627-122B7 | 142.49 | 64.48 | 13.52 | 0.00 | 0.00 |
Mesenchymal Stem Cells - bone marrow, donor1.CNhs11344.11536-120A6 | 218.11 | 50.93 | 18.26 | 3.60 | 1.03 |
Mesenchymal Stem Cells - bone marrow, donor2.CNhs12100.11616-122A5 | 139.01 | 43.97 | 25.53 | 1.42 | 0.00 |
Mesenchymal Stem Cells - bone marrow, donor3.CNhs12126.11697-123A5 | 167.58 | 53.02 | 28.77 | 0.00 | 1.33 |
Mesenchymal Stem Cells - hepatic, donor2.CNhs12730.11618-122A7 | 185.44 | 91.51 | 13.30 | 3.57 | 1.29 |
Mesenchymal Stem Cells - umbilical, donor1.CNhs11347.11539-120A9 | 205.65 | 185.03 | 21.70 | 0.54 | 2.71 |
Mesenchymal Stem Cells - umbilical, donor3.CNhs12127.11700-123A8 | 239.56 | 66.68 | 19.76 | 1.65 | 1.65 |
Mesenchymal stem cells - adipose, donor0.CNhs10844.11217-116B2 | 207.82 | 66.12 | 30.62 | 0.98 | 1.30 |
Mesenchymal stem cells - hepatic, donor0.CNhs10845.11218-116B3 | 172.37 | 90.62 | 17.41 | 1.42 | 1.42 |
Mesenchymal stem cells - umbilical, donor0.CNhs12492.11214-116A8 | 186.90 | 64.15 | 24.55 | 0.00 | 0.00 |
Mesothelial Cells, donor1.CNhs10850.11247-116E5 | 171.82 | 50.34 | 37.68 | 3.01 | 6.33 |
Mesothelial Cells, donor2.CNhs12197.12156-128G5 | 176.05 | 70.59 | 58.39 | 4.36 | 7.84 |
Mesothelial Cells, donor3.CNhs12012.11402-118D7 | 145.96 | 62.58 | 35.99 | 4.30 | 3.30 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h).CNhs13646.13317-143A5 | 71.76 | 189.73 | 6.08 | 1.22 | 21.89 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h).CNhs13650.13323-143B2 | 60.77 | 235.06 | 13.06 | 1.00 | 26.62 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h).CNhs13639.13311-142I8 | 65.36 | 177.10 | 8.43 | 2.11 | 16.87 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1.CNhs11350.11549-120C1 | 174.45 | 63.98 | 28.52 | 2.40 | 4.07 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2.CNhs12105.11629-122B9 | 137.83 | 83.85 | 10.34 | 8.04 | 0.00 |
Myoblast differentiation to myotubes, day00, control donor1.CNhs13847.13469-144I4 | 68.47 | 31.38 | 11.41 | 2.85 | 4.28 |
Myoblast, donor1.CNhs10870.11241-116D8 | 153.32 | 55.74 | 44.45 | 3.04 | 3.91 |
Myoblast, donor2.CNhs11965.11322-117D8 | 122.26 | 40.89 | 18.08 | 3.49 | 0.82 |
Myoblast, donor3.CNhs11908.11398-118D3 | 120.15 | 38.50 | 18.26 | 2.86 | 4.48 |
NK T cell leukemia cell line:KHYG-1.CNhs11867.10777-110G3 | 109.51 | 85.18 | 10.42 | 10.20 | 2.24 |
Natural Killer Cells, donor1.CNhs10859.11230-116C6 | 82.56 | 122.95 | 19.51 | 1.77 | 5.12 |
Natural Killer Cells, donor2.CNhs11957.11311-117C6 | 67.06 | 98.54 | 16.39 | 4.53 | 2.59 |
Natural Killer Cells, donor3.CNhs12001.11387-118C1 | 62.25 | 99.08 | 14.12 | 1.67 | 3.47 |
Neural stem cells, donor1.CNhs11063.11275-116H6 | 76.99 | 20.58 | 8.64 | 11.94 | 0.51 |
Neural stem cells, donor2.CNhs11384.11352-117H2 | 74.18 | 18.22 | 11.71 | 11.71 | 1.30 |
Neurons, donor1.CNhs12338.11494-119E9 | 66.50 | 17.01 | 13.15 | 3.87 | 1.55 |
Neurons, donor2.CNhs12726.11574-120E8 | 58.30 | 16.08 | 7.20 | 5.86 | 0.50 |
Neurons, donor3.CNhs13815.11655-122E8 | 65.71 | 15.95 | 14.03 | 4.47 | 3.83 |
Neutrophils, donor1.CNhs10862.11233-116C9 | 27.71 | 205.23 | 6.74 | 0.00 | 64.41 |
Neutrophils, donor2.CNhs11959.11314-117C9 | 26.92 | 137.61 | 8.97 | 0.00 | 38.89 |
Neutrophils, donor3.CNhs11905.11390-118C4 | 36.47 | 177.37 | 12.85 | 0.41 | 93.66 |
Nucleus Pulposus Cell, donor1.CNhs10881.11252-116F1 | 101.83 | 50.43 | 6.26 | 9.32 | 0.25 |
Nucleus Pulposus Cell, donor2.CNhs12019.11409-118E5 | 113.54 | 62.52 | 8.50 | 9.50 | 1.00 |
Nucleus Pulposus Cell, donor3.CNhs12063.11462-119B4 | 119.09 | 48.01 | 9.49 | 2.44 | 1.09 |
Olfactory epithelial cells, donor1.CNhs13816.11933-125I7 | 138.92 | 73.00 | 20.59 | 1.66 | 3.33 |
Olfactory epithelial cells, donor2.CNhs13817.11934-125I8 | 149.88 | 57.81 | 24.80 | 2.50 | 1.43 |
Olfactory epithelial cells, donor3.CNhs13818.11935-125I9 | 155.18 | 77.12 | 22.71 | 2.52 | 1.89 |
Olfactory epithelial cells, donor4.CNhs13819.11936-126A1 | 171.14 | 82.94 | 28.58 | 1.52 | 1.99 |
Osteoblast - differentiated, donor1.CNhs11311.11276-116H7 | 133.62 | 98.71 | 21.37 | 1.81 | 1.20 |
Osteoblast - differentiated, donor2.CNhs11980.11353-117H3 | 111.43 | 70.50 | 11.37 | 2.27 | 2.27 |
Osteoblast - differentiated, donor3.CNhs12035.11425-118G3 | 135.55 | 118.99 | 21.73 | 1.03 | 3.10 |
Osteoblast, donor2.CNhs11385.11354-117H4 | 180.67 | 48.49 | 17.93 | 1.99 | 1.99 |
Osteoblast, donor3.CNhs12036.11426-118G4 | 144.18 | 53.28 | 26.55 | 0.55 | 1.29 |
Pancreatic stromal cells, donor1.CNhs10877.11249-116E7 | 146.14 | 53.43 | 16.51 | 4.00 | 1.30 |
Pericytes, donor1.CNhs11317.11491-119E6 | 126.29 | 62.85 | 8.22 | 3.72 | 0.59 |
Pericytes, donor2.CNhs12079.11571-120E5 | 111.86 | 57.65 | 13.73 | 2.75 | 2.06 |
Peripheral Blood Mononuclear Cells, donor1.CNhs10860.11231-116C7 | 55.00 | 171.82 | 6.41 | 2.27 | 10.34 |
Peripheral Blood Mononuclear Cells, donor2.CNhs11958.11312-117C7 | 43.36 | 176.02 | 11.00 | 1.94 | 15.96 |
Peripheral Blood Mononuclear Cells, donor3.CNhs12002.11388-118C2 | 47.60 | 164.36 | 12.81 | 1.71 | 16.97 |
Placental Epithelial Cells, donor1.CNhs11079.11278-116H9 | 123.68 | 31.83 | 20.61 | 0.30 | 3.64 |
Placental Epithelial Cells, donor2.CNhs11386.11355-117H5 | 189.74 | 41.61 | 8.32 | 4.99 | 4.99 |
Placental Epithelial Cells, donor3.CNhs12037.11427-118G5 | 101.00 | 55.64 | 12.70 | 0.91 | 1.51 |
Preadipocyte - breast, donor1.CNhs11052.11467-119B9 | 197.49 | 59.55 | 24.81 | 2.23 | 2.98 |
Preadipocyte - breast, donor2 (nuclear fraction).CNhs12584.14320-155D9 | 99.90 | 22.41 | 20.26 | 1.23 | 0.61 |
Preadipocyte - breast, donor2.CNhs11971.11328-117E5 | 200.95 | 75.22 | 37.33 | 0.56 | 4.49 |
Preadipocyte - omental, donor1.CNhs11065.11468-119C1 | 153.38 | 39.98 | 22.81 | 2.05 | 2.56 |
Preadipocyte - omental, donor2.CNhs11902.11329-117E6 | 155.56 | 51.17 | 29.17 | 2.05 | 2.05 |
Preadipocyte - omental, donor3.CNhs12013.11403-118D8 | 185.46 | 70.29 | 36.03 | 1.77 | 4.66 |
Preadipocyte - perirenal, donor1.CNhs12065.11469-119C2 | 146.93 | 87.57 | 41.56 | 0.00 | 0.00 |
Preadipocyte - subcutaneous, donor2.CNhs11981.11356-117H6 | 229.62 | 54.59 | 35.01 | 1.85 | 1.08 |
Preadipocyte - subcutaneous, donor3.CNhs12038.11428-118G6 | 243.61 | 69.25 | 46.34 | 1.60 | 3.02 |
Preadipocyte - visceral, donor1.CNhs11082.11280-116I2 | 171.73 | 53.63 | 27.18 | 3.78 | 2.22 |
Preadipocyte - visceral, donor2.CNhs11982.11357-117H7 | 196.80 | 59.71 | 27.00 | 3.63 | 2.60 |
Preadipocyte - visceral, donor3.CNhs12039.11429-118G7 | 159.56 | 48.58 | 34.28 | 1.05 | 1.28 |
Prostate Epithelial Cells (polarized), donor1.CNhs10882.11253-116F2 | 130.77 | 68.29 | 28.04 | 7.98 | 3.75 |
Prostate Epithelial Cells, donor2.CNhs11972.11331-117E8 | 144.97 | 53.33 | 42.11 | 7.82 | 4.61 |
Prostate Epithelial Cells, donor3.CNhs12014.11404-118D9 | 233.24 | 102.03 | 32.04 | 9.67 | 1.57 |
Prostate Stromal Cells, donor1.CNhs10883.11254-116F3 | 195.07 | 52.81 | 29.05 | 3.67 | 2.87 |
Prostate Stromal Cells, donor2.CNhs11973.11332-117E9 | 241.09 | 69.01 | 48.62 | 3.10 | 1.09 |
Prostate Stromal Cells, donor3.CNhs12015.11405-118E1 | 144.76 | 67.40 | 19.01 | 2.49 | 1.05 |
Renal Cortical Epithelial Cells, donor1.CNhs11331.11516-119H4 | 113.25 | 95.20 | 15.34 | 1.35 | 0.45 |
Renal Cortical Epithelial Cells, donor2.CNhs12728.11596-120H3 | 113.98 | 53.45 | 10.17 | 4.54 | 1.00 |
Renal Epithelial Cells, donor1.CNhs11332.11517-119H5 | 168.64 | 77.65 | 19.61 | 1.57 | 0.78 |
Renal Epithelial Cells, donor2.CNhs12088.11597-120H4 | 89.14 | 43.84 | 11.69 | 1.46 | 1.46 |
Renal Epithelial Cells, donor3.CNhs12732.11678-122H4 | 109.98 | 35.15 | 8.34 | 3.48 | 1.06 |
Renal Glomerular Endothelial Cells, donor1.CNhs12074.11514-119H2 | 70.51 | 94.40 | 7.96 | 0.00 | 2.27 |
Renal Glomerular Endothelial Cells, donor2.CNhs12086.11594-120H1 | 85.73 | 72.63 | 15.65 | 1.70 | 1.53 |
Renal Glomerular Endothelial Cells, donor3.CNhs12624.11675-122H1 | 110.55 | 65.64 | 16.84 | 1.73 | 1.51 |
Renal Glomerular Endothelial Cells, donor4.CNhs13080.11783-124B1 | 155.77 | 254.47 | 13.88 | 3.08 | 10.80 |
Renal Mesangial Cells, donor1.CNhs11333.11518-119H6 | 134.39 | 46.87 | 12.46 | 1.35 | 1.08 |
Renal Mesangial Cells, donor3.CNhs12121.11679-122H5 | 111.88 | 59.20 | 14.05 | 0.50 | 1.00 |
Renal Proximal Tubular Epithelial Cell, donor1.CNhs11330.11515-119H3 | 152.16 | 68.31 | 17.08 | 0.25 | 1.27 |
Renal Proximal Tubular Epithelial Cell, donor2.CNhs12087.11595-120H2 | 170.37 | 98.90 | 36.57 | 1.66 | 1.66 |
Renal Proximal Tubular Epithelial Cell, donor3.CNhs12120.11676-122H2 | 92.68 | 53.28 | 9.63 | 2.24 | 0.90 |
Reticulocytes, biol_rep1.CNhs13552.11931-125I5 | 82.00 | 28.72 | 10.96 | 2.41 | 1.10 |
Reticulocytes, biol_rep2.CNhs13553.11932-125I6 | 88.89 | 33.99 | 12.03 | 4.71 | 0.52 |
Retinal Pigment Epithelial Cells, donor0.CNhs10842.11215-116A9 | 86.94 | 28.72 | 6.41 | 2.31 | 0.26 |
Retinal Pigment Epithelial Cells, donor1.CNhs11338.11528-119I7 | 72.49 | 36.41 | 7.22 | 1.97 | 0.33 |
Retinal Pigment Epithelial Cells, donor3.CNhs12733.11689-122I6 | 94.36 | 34.82 | 4.56 | 5.86 | 0.98 |
SABiosciences XpressRef Human Universal Total RNA, pool1.CNhs10610.10002-101A5 | 149.00 | 104.59 | 27.92 | 9.69 | 5.98 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0).CNhs12859.12760-136B6 | 111.07 | 49.36 | 27.01 | 11.81 | 1.74 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0).CNhs12952.12858-137D5 | 109.49 | 45.88 | 20.54 | 15.68 | 1.65 |
Sebocyte, donor1.CNhs10847.11220-116B5 | 122.32 | 55.70 | 21.82 | 1.72 | 1.72 |
Sebocyte, donor2.CNhs11951.11301-117B5 | 139.76 | 59.81 | 29.25 | 2.60 | 1.95 |
Sertoli Cells, donor1.CNhs10851.11255-116F4 | 128.55 | 67.49 | 20.89 | 0.00 | 1.61 |
Skeletal Muscle Cells, donor1.CNhs11083.11281-116I3 | 98.51 | 55.88 | 7.64 | 3.96 | 1.55 |
Skeletal Muscle Cells, donor4.CNhs12053.11451-119A2 | 149.58 | 44.83 | 27.11 | 4.93 | 0.92 |
Skeletal Muscle Cells, donor5.CNhs12056.11455-119A6 | 146.75 | 44.98 | 25.79 | 3.84 | 0.46 |
Skeletal Muscle Cells, donor6.CNhs12060.11459-119B1 | 166.23 | 43.83 | 21.09 | 2.21 | 1.38 |
Skeletal Muscle Satellite Cells, donor1.CNhs10869.11240-116D7 | 135.99 | 61.12 | 11.49 | 8.49 | 0.43 |
Skeletal Muscle Satellite Cells, donor2.CNhs11964.11321-117D7 | 158.07 | 55.11 | 13.05 | 7.40 | 1.74 |
Skeletal Muscle Satellite Cells, donor3.CNhs12008.11397-118D2 | 154.60 | 49.09 | 20.80 | 1.53 | 1.36 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1.CNhs11084.11282-116I4 | 120.28 | 48.70 | 16.92 | 2.58 | 0.62 |
Small Airway Epithelial Cells, donor1.CNhs10884.11256-116F5 | 242.31 | 102.64 | 46.61 | 7.60 | 3.64 |
Small Airway Epithelial Cells, donor2.CNhs11975.11334-117F2 | 163.55 | 97.44 | 49.01 | 4.80 | 4.23 |
Small Airway Epithelial Cells, donor3 (nuclear fraction).CNhs12583.14317-155D6 | 46.96 | 19.14 | 14.55 | 8.42 | 0.51 |
Small Airway Epithelial Cells, donor3.CNhs12016.11406-118E2 | 325.53 | 119.77 | 68.79 | 3.03 | 4.35 |
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction).CNhs12401.14313-155D2 | 310.05 | 107.38 | 81.81 | 5.11 | 1.39 |
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction).CNhs12402.14314-155D3 | 131.59 | 41.24 | 29.28 | 3.46 | 1.89 |
Smooth Muscle Cells - Aortic, donor0.CNhs10838.11210-116A4 | 197.96 | 76.67 | 43.22 | 2.79 | 4.88 |
Smooth Muscle Cells - Aortic, donor1.CNhs11085.11283-116I5 | 137.38 | 85.94 | 38.81 | 2.16 | 2.46 |
Smooth Muscle Cells - Aortic, donor2.CNhs11305.11360-117I1 | 153.84 | 91.02 | 61.22 | 1.60 | 4.79 |
Smooth Muscle Cells - Aortic, donor3.CNhs11309.11432-118H1 | 206.17 | 97.43 | 41.76 | 1.74 | 4.35 |
Smooth Muscle Cells - Brachiocephalic, donor1.CNhs11086.11284-116I6 | 201.08 | 102.11 | 64.12 | 1.48 | 5.37 |
Smooth Muscle Cells - Brachiocephalic, donor3.CNhs12043.11433-118H2 | 143.12 | 98.47 | 64.12 | 5.30 | 12.88 |
Smooth Muscle Cells - Brain Vascular, donor1.CNhs10863.11234-116D1 | 157.42 | 55.45 | 18.61 | 4.09 | 0.74 |
Smooth Muscle Cells - Brain Vascular, donor2.CNhs11900.11315-117D1 | 150.60 | 42.71 | 17.08 | 1.90 | 1.27 |
Smooth Muscle Cells - Brain Vascular, donor3.CNhs12004.11391-118C5 | 173.28 | 74.16 | 31.07 | 2.29 | 1.91 |
Smooth Muscle Cells - Bronchial, donor1.CNhs11328.11512-119G9 | 282.26 | 64.23 | 22.01 | 2.56 | 2.56 |
Smooth Muscle Cells - Bronchial, donor2.CNhs12348.11592-120G8 | 123.25 | 53.92 | 11.55 | 5.56 | 2.14 |
Smooth Muscle Cells - Carotid, donor1.CNhs11087.11285-116I7 | 111.37 | 52.82 | 14.00 | 2.55 | 0.64 |
Smooth Muscle Cells - Carotid, donor3.CNhs12044.11434-118H3 | 188.39 | 112.25 | 77.71 | 5.49 | 3.92 |
Smooth Muscle Cells - Colonic, donor1.CNhs10868.11239-116D6 | 198.22 | 49.11 | 25.90 | 5.04 | 0.90 |
Smooth Muscle Cells - Colonic, donor2.CNhs11963.11320-117D6 | 204.53 | 61.77 | 28.00 | 3.02 | 1.37 |
Smooth Muscle Cells - Colonic, donor3.CNhs12007.11396-118D1 | 199.93 | 61.85 | 31.57 | 3.42 | 0.94 |
Smooth Muscle Cells - Coronary Artery, donor1.CNhs11088.11286-116I8 | 163.77 | 101.09 | 60.45 | 1.42 | 6.07 |
Smooth Muscle Cells - Coronary Artery, donor2.CNhs11987.11363-117I4 | 161.68 | 114.13 | 50.72 | 4.76 | 7.93 |
Smooth Muscle Cells - Coronary Artery, donor3.CNhs12045.11435-118H4 | 160.08 | 91.41 | 60.66 | 3.37 | 6.74 |
Smooth Muscle Cells - Esophageal, donor1.CNhs11324.11508-119G5 | 247.23 | 81.43 | 35.60 | 1.95 | 1.46 |
Smooth Muscle Cells - Internal Thoracic Artery, donor2.CNhs11988.11364-117I5 | 140.62 | 77.01 | 56.54 | 7.31 | 5.12 |
Smooth Muscle Cells - Internal Thoracic Artery, donor3.CNhs12046.11436-118H5 | 188.06 | 110.93 | 57.05 | 4.23 | 3.17 |
Smooth Muscle Cells - Prostate, donor1.CNhs11920.11257-116F6 | 156.70 | 52.01 | 23.48 | 3.82 | 1.91 |
Smooth Muscle Cells - Prostate, donor2.CNhs11976.11335-117F3 | 176.62 | 60.24 | 22.20 | 3.54 | 2.55 |
Smooth Muscle Cells - Pulmonary Artery, donor2.CNhs11989.11365-117I6 | 113.01 | 67.80 | 22.60 | 3.39 | 0.00 |
Smooth Muscle Cells - Subclavian Artery, donor1.CNhs11090.11289-117A2 | 192.43 | 81.05 | 34.74 | 0.00 | 2.21 |
Smooth Muscle Cells - Subclavian Artery, donor2.CNhs11990.11366-117I7 | 161.22 | 122.74 | 77.62 | 5.97 | 8.62 |
Smooth Muscle Cells - Subclavian Artery, donor3.CNhs12048.11438-118H7 | 134.17 | 83.74 | 84.18 | 5.26 | 7.89 |
Smooth Muscle Cells - Tracheal, donor1.CNhs11329.11513-119H1 | 179.42 | 56.72 | 14.47 | 1.74 | 1.74 |
Smooth Muscle Cells - Tracheal, donor3.CNhs12894.11674-122G9 | 121.34 | 56.41 | 7.87 | 5.25 | 1.97 |
Smooth Muscle Cells - Umbilical Artery, donor1.CNhs11091.11290-117A3 | 191.75 | 163.95 | 112.21 | 2.03 | 11.36 |
Smooth Muscle Cells - Umbilical Artery, donor2.CNhs11991.11367-117I8 | 182.18 | 105.96 | 62.27 | 3.72 | 7.13 |
Smooth Muscle Cells - Umbilical Artery, donor3.CNhs12049.11439-118H8 | 143.38 | 88.17 | 42.54 | 0.85 | 3.10 |
Smooth Muscle Cells - Umbilical Vein, donor1.CNhs12597.11541-120B2 | 150.58 | 49.33 | 14.91 | 2.01 | 1.43 |
Smooth Muscle Cells - Umbilical Vein, donor2.CNhs12569.11621-122B1 | 195.91 | 84.30 | 19.55 | 0.98 | 1.57 |
Smooth Muscle Cells - Umbilical artery, donor0.CNhs10839.11212-116A6 | 164.43 | 151.23 | 91.66 | 2.50 | 14.98 |
Smooth Muscle Cells - Uterine, donor3.CNhs11927.11466-119B8 | 143.32 | 50.02 | 23.06 | 3.55 | 1.42 |
Synoviocyte, donor2.CNhs11992.11368-117I9 | 117.38 | 71.99 | 16.47 | 3.80 | 2.11 |
Synoviocyte, donor3.CNhs12050.11440-118H9 | 124.80 | 69.15 | 11.20 | 5.93 | 1.98 |
Trabecular Meshwork Cells, donor1.CNhs11340.11532-120A2 | 158.24 | 58.82 | 16.32 | 3.04 | 1.90 |
Trabecular Meshwork Cells, donor3.CNhs12124.11693-123A1 | 154.67 | 82.23 | 18.20 | 4.20 | 0.70 |
Tracheal Epithelial Cells, donor1.CNhs11092.11292-117A5 | 166.46 | 93.91 | 26.46 | 2.60 | 1.35 |
Tracheal Epithelial Cells, donor2.CNhs11993.11369-118A1 | 93.17 | 60.33 | 21.45 | 1.34 | 1.34 |
Tracheal Epithelial Cells, donor3.CNhs12051.11441-118I1 | 104.54 | 78.40 | 38.11 | 1.09 | 2.18 |
Universal RNA - Human Normal Tissues Biochain, pool1.CNhs10612.10007-101B4 | 146.39 | 98.10 | 27.11 | 8.66 | 6.21 |
Urothelial Cells, donor1.CNhs11334.11520-119H8 | 200.62 | 100.74 | 27.12 | 1.72 | 3.01 |
Urothelial Cells, donor2.CNhs12091.11600-120H7 | 131.41 | 85.92 | 18.53 | 0.00 | 5.05 |
Urothelial Cells, donor3.CNhs12122.11681-122H7 | 156.53 | 125.05 | 28.38 | 3.10 | 0.44 |
Urothelial cells, donor0.CNhs10843.11216-116B1 | 178.50 | 103.15 | 23.66 | 4.14 | 1.61 |
Whole blood (ribopure), donor090309, donation1.CNhs11675.12179-129A1 | 56.33 | 130.92 | 7.10 | 3.04 | 13.19 |
Whole blood (ribopure), donor090309, donation2.CNhs11671.12180-129A2 | 56.58 | 123.11 | 4.59 | 3.82 | 11.47 |
Whole blood (ribopure), donor090309, donation3.CNhs11948.12181-129A3 | 54.69 | 136.72 | 11.39 | 3.99 | 7.98 |
Whole blood (ribopure), donor090325, donation1.CNhs11075.12176-128I7 | 56.70 | 142.46 | 6.19 | 6.19 | 11.44 |
Whole blood (ribopure), donor090325, donation2.CNhs11076.12177-128I8 | 61.70 | 148.50 | 6.17 | 4.11 | 15.22 |
Whole blood (ribopure), donor090612, donation1.CNhs11672.12182-129A4 | 46.04 | 129.05 | 5.19 | 1.30 | 16.86 |
Whole blood (ribopure), donor090612, donation2.CNhs11673.12183-129A5 | 57.78 | 133.93 | 8.64 | 4.32 | 9.18 |
Whole blood (ribopure), donor090612, donation3.CNhs11949.12184-129A6 | 53.93 | 127.69 | 7.93 | 3.17 | 11.10 |
Wilms' tumor cell line:G-401.CNhs11892.10809-111A8 | 76.49 | 26.39 | 9.51 | 3.53 | 0.53 |
Wilms' tumor cell line:HFWT.CNhs11728.10597-108E3 | 59.67 | 20.21 | 6.74 | 6.74 | 0.00 |
acantholytic squamous carcinoma cell line:HCC1806.CNhs11844.10717-109I6 | 140.41 | 75.72 | 21.56 | 1.47 | 2.70 |
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1.CNhs11251.10455-106G5 | 80.08 | 170.57 | 20.62 | 15.42 | 9.66 |
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6.CNhs11282.10534-107G3 | 49.48 | 163.60 | 12.98 | 4.18 | 1.30 |
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL.CNhs10746.10429-106D6 | 103.87 | 129.91 | 17.93 | 9.39 | 1.00 |
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat.CNhs11253.10464-106H5 | 121.64 | 102.19 | 32.20 | 3.67 | 0.64 |
acute myeloid leukemia (FAB M0) cell line:KG-1.CNhs13053.10827-111C8 | 61.27 | 90.61 | 15.17 | 4.99 | 4.19 |
acute myeloid leukemia (FAB M0) cell line:Kasumi-3.CNhs13241.10789-110H6 | 47.30 | 151.10 | 8.23 | 3.64 | 5.75 |
acute myeloid leukemia (FAB M1) cell line:HYT-1.CNhs13054.10828-111C9 | 73.03 | 274.54 | 11.85 | 8.47 | 4.66 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-1.CNhs13502.10788-110H5 | 34.73 | 216.52 | 10.39 | 1.62 | 5.19 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-6.CNhs13052.10792-110H9 | 58.41 | 295.96 | 17.97 | 14.04 | 7.02 |
acute myeloid leukemia (FAB M2) cell line:NKM-1.CNhs11864.10765-110E9 | 36.52 | 149.72 | 9.81 | 2.74 | 3.20 |
acute myeloid leukemia (FAB M3) cell line:HL60.CNhs13055.10829-111D1 | 34.94 | 158.72 | 7.05 | 2.82 | 7.83 |
acute myeloid leukemia (FAB M4) cell line:FKH-1.CNhs13503.10830-111D2 | 32.58 | 147.87 | 5.01 | 2.51 | 0.00 |
acute myeloid leukemia (FAB M4) cell line:HNT-34.CNhs13504.10831-111D3 | 46.72 | 101.91 | 7.96 | 4.06 | 3.05 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-1.CNhs13056.10832-111D4 | 31.48 | 135.70 | 8.19 | 2.25 | 2.57 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-3.CNhs13057.10833-111D5 | 35.52 | 183.03 | 8.68 | 1.82 | 5.04 |
acute myeloid leukemia (FAB M5) cell line:NOMO-1.CNhs13050.10764-110E8 | 38.75 | 196.32 | 9.79 | 4.26 | 12.78 |
acute myeloid leukemia (FAB M5) cell line:P31/FUJ.CNhs13051.10770-110F5 | 37.10 | 145.99 | 5.84 | 2.75 | 5.84 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh).CNhs10722.10399-106A3 | 29.50 | 137.34 | 13.52 | 3.38 | 3.99 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived).CNhs10723.10400-106A4 | 35.12 | 148.52 | 11.41 | 4.25 | 4.25 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed).CNhs10724.10405-106A9 | 34.87 | 146.83 | 13.68 | 2.34 | 6.17 |
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4.CNhs13058.10834-111D6 | 57.05 | 168.82 | 14.26 | 4.49 | 3.71 |
acute myeloid leukemia (FAB M6) cell line:EEB.CNhs13059.10835-111D7 | 96.33 | 32.57 | 13.92 | 8.91 | 1.11 |
acute myeloid leukemia (FAB M6) cell line:F-36E.CNhs13060.10836-111D8 | 72.62 | 67.70 | 16.00 | 1.23 | 1.23 |
acute myeloid leukemia (FAB M6) cell line:F-36P.CNhs13505.10837-111D9 | 83.03 | 125.76 | 14.06 | 4.87 | 0.81 |
acute myeloid leukemia (FAB M7) cell line:M-MOK.CNhs13049.10699-109G6 | 62.95 | 93.93 | 9.33 | 5.33 | 3.33 |
acute myeloid leukemia (FAB M7) cell line:MKPL-1.CNhs11888.10802-111A1 | 36.66 | 114.20 | 9.87 | 8.46 | 2.82 |
adenocarcinoma cell line:IM95m.CNhs11882.10796-110I4 | 122.39 | 89.27 | 18.53 | 6.18 | 0.94 |
adipose tissue, adult, pool1.CNhs10615.10010-101C1 | 72.23 | 68.13 | 5.71 | 4.40 | 4.40 |
adrenal cortex adenocarcinoma cell line:SW-13.CNhs11893.10810-111A9 | 54.13 | 8.25 | 2.91 | 5.46 | 0.49 |
adult T-cell leukemia cell line:ATN-1.CNhs10738.10421-106C7 | 80.13 | 122.03 | 12.26 | 4.79 | 1.56 |
alveolar cell carcinoma cell line:SW 1573.CNhs11838.10708-109H6 | 82.97 | 32.11 | 11.37 | 1.42 | 0.85 |
amniotic membrane cells, donor1.CNhs12502.12235-129G3 | 173.57 | 59.69 | 32.71 | 4.06 | 5.01 |
amniotic membrane cells, donor2.CNhs12503.12236-129G4 | 158.28 | 56.42 | 16.04 | 10.10 | 1.19 |
amniotic membrane cells, donor3.CNhs12379.12237-129G5 | 127.16 | 80.48 | 21.19 | 11.67 | 2.76 |
amygdala - adult, donor10196.CNhs13793.10167-103B5 | 75.56 | 23.86 | 22.87 | 13.92 | 7.95 |
amygdala, adult, donor10252.CNhs12311.10151-102I7 | 86.37 | 28.42 | 16.04 | 12.66 | 3.09 |
anaplastic carcinoma cell line:8305C.CNhs10745.10428-106D5 | 132.79 | 174.87 | 23.37 | 3.01 | 5.57 |
anaplastic large cell lymphoma cell line:Ki-JK.CNhs11881.10795-110I3 | 99.87 | 101.85 | 21.92 | 3.30 | 1.32 |
anaplastic squamous cell carcinoma cell line:RPMI 2650.CNhs11889.10805-111A4 | 27.24 | 26.18 | 9.92 | 9.50 | 4.64 |
aorta, adult, pool1.CNhs11760.10052-101G7 | 111.38 | 70.14 | 17.53 | 3.19 | 4.58 |
appendix, adult.CNhs12842.10189-103D9 | 61.61 | 90.34 | 13.81 | 12.16 | 5.25 |
argyrophil small cell carcinoma cell line:TC-YIK.CNhs11725.10589-108D4 | 70.29 | 61.47 | 9.07 | 4.53 | 2.52 |
astrocytoma cell line:TM-31.CNhs10742.10425-106D2 | 76.19 | 24.95 | 5.62 | 10.23 | 1.12 |
b cell line:RPMI1788.CNhs10744.10427-106D4 | 390.30 | 560.28 | 75.08 | 30.16 | 9.72 |
basal cell carcinoma cell line:TE 354.T.CNhs11932.10702-109G9 | 164.54 | 51.32 | 32.04 | 0.93 | 1.56 |
bile duct carcinoma cell line:HuCCT1.CNhs10750.10432-106D9 | 101.10 | 108.65 | 17.70 | 5.12 | 3.06 |
bile duct carcinoma cell line:TFK-1.CNhs11265.10496-107C1 | 264.24 | 84.32 | 32.94 | 2.86 | 1.97 |
biphenotypic B myelomonocytic leukemia cell line:MV-4-11.CNhs11845.10718-109I7 | 23.02 | 168.31 | 6.65 | 4.60 | 7.16 |
bladder, adult, pool1.CNhs10616.10011-101C2 | 109.59 | 100.12 | 14.40 | 9.17 | 1.18 |
blood, adult, pool1.CNhs11761.10053-101G8 | 86.21 | 165.24 | 4.79 | 4.79 | 9.58 |
bone marrow stromal cell line:StromaNKtert.CNhs11931.10686-109F2 | 84.46 | 62.24 | 18.89 | 2.22 | 2.22 |
brain, adult, donor1.CNhs11796.10084-102B3 | 72.70 | 24.23 | 14.54 | 4.85 | 0.97 |
brain, adult, pool1.CNhs10617.10012-101C3 | 71.52 | 30.15 | 11.50 | 10.48 | 3.99 |
brain, fetal, pool1.CNhs11797.10085-102B4 | 51.90 | 39.92 | 17.97 | 9.98 | 0.00 |
breast carcinoma cell line:MCF7.CNhs11943.10482-107A5 | 118.49 | 73.44 | 18.23 | 8.07 | 2.60 |
breast carcinoma cell line:MDA-MB-453.CNhs10736.10419-106C5 | 173.35 | 53.35 | 35.07 | 3.32 | 2.10 |
breast, adult, donor1.CNhs11792.10080-102A8 | 137.02 | 123.97 | 28.27 | 0.72 | 4.35 |
bronchial squamous cell carcinoma cell line:KNS-62.CNhs11862.10760-110E4 | 115.39 | 26.97 | 7.06 | 4.55 | 0.46 |
bronchioalveolar carcinoma cell line:NCI-H358.CNhs11840.10709-109H7 | 70.94 | 24.92 | 7.37 | 6.61 | 1.02 |
bronchogenic carcinoma cell line:ChaGo-K-1.CNhs11841.10710-109H8 | 139.23 | 61.46 | 15.84 | 6.86 | 3.31 |
carcinoid cell line:NCI-H1770.CNhs11834.10703-109H1 | 94.11 | 21.03 | 6.21 | 2.41 | 0.00 |
carcinoid cell line:SK-PN-DW.CNhs11846.10719-109I8 | 157.47 | 87.77 | 22.75 | 6.71 | 0.87 |
carcinosarcoma cell line:JHUCS-1.CNhs11747.10642-109A3 | 56.60 | 24.13 | 6.08 | 6.77 | 0.17 |
caudate nucleus - adult, donor10196.CNhs13802.10177-103C6 | 79.72 | 27.46 | 8.86 | 16.83 | 7.97 |
caudate nucleus, adult, donor10252.CNhs12321.10164-103B2 | 99.25 | 27.98 | 22.19 | 16.64 | 1.69 |
cerebellum - adult, donor10196.CNhs13799.10173-103C2 | 70.19 | 22.89 | 15.26 | 10.68 | 0.00 |
cerebellum, adult, donor10252.CNhs12323.10166-103B4 | 57.39 | 10.06 | 10.62 | 12.83 | 1.66 |
cerebellum, adult, pool1.CNhs11795.10083-102B2 | 57.04 | 22.17 | 12.71 | 7.09 | 2.96 |
cerebral meninges, adult.CNhs12840.10188-103D8 | 82.05 | 41.03 | 31.37 | 13.38 | 7.68 |
cervical cancer cell line:D98-AH2.CNhs11288.10552-107I3 | 193.47 | 162.10 | 29.74 | 11.00 | 3.49 |
cervical cancer cell line:ME-180.CNhs11289.10553-107I4 | 212.20 | 124.23 | 64.83 | 14.78 | 4.46 |
cervix, adult, pool1.CNhs10618.10013-101C4 | 112.81 | 67.33 | 16.39 | 6.62 | 1.92 |
cholangiocellular carcinoma cell line:HuH-28.CNhs11283.10536-107G5 | 123.29 | 23.24 | 13.90 | 5.81 | 1.37 |
choriocarcinoma cell line:T3M-3.CNhs11820.10618-108G6 | 116.90 | 71.94 | 12.91 | 12.45 | 0.92 |
choriocarcinoma cell line:BeWo.CNhs10740.10423-106C9 | 145.23 | 76.29 | 17.41 | 8.17 | 1.26 |
choriocarcinoma cell line:SCH.CNhs11875.10785-110H2 | 213.93 | 70.08 | 33.14 | 48.67 | 1.74 |
chorionic membrane cells, donor1.CNhs12504.12238-129G6 | 227.13 | 61.25 | 39.56 | 2.87 | 4.47 |
chorionic membrane cells, donor2.CNhs12506.12239-129G7 | 164.60 | 40.39 | 21.98 | 1.92 | 1.01 |
chorionic membrane cells, donor3.CNhs12380.12240-129G8 | 171.10 | 75.69 | 25.59 | 10.13 | 1.60 |
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3.CNhs11714.10416-106C2 | 82.78 | 154.31 | 18.39 | 11.24 | 4.09 |
chronic myeloblastic leukemia (CML) cell line:KCL-22.CNhs11886.10801-110I9 | 67.50 | 150.07 | 12.72 | 3.77 | 8.16 |
chronic myelogenous leukemia (CML) cell line:MEG-A2.CNhs11865.10766-110F1 | 44.71 | 130.31 | 9.64 | 1.66 | 6.15 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1.CNhs12334.10824-111C5 | 184.09 | 66.10 | 20.98 | 11.51 | 1.35 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2.CNhs12335.10825-111C6 | 174.69 | 66.27 | 25.68 | 12.55 | 1.18 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3.CNhs12336.10826-111C7 | 166.81 | 65.79 | 24.50 | 16.61 | 1.34 |
chronic myelogenous leukemia cell line:K562.CNhs11250.10454-106G4 | 94.50 | 28.08 | 13.47 | 3.42 | 1.14 |
chronic myelogenous leukemia cell line:KU812.CNhs10727.10409-106B4 | 71.20 | 115.23 | 15.42 | 2.54 | 2.07 |
clear cell carcinoma cell line:JHOC-5.CNhs11745.10638-108I8 | 139.68 | 38.82 | 12.66 | 1.48 | 1.90 |
clear cell carcinoma cell line:TEN.CNhs11930.10636-108I6 | 145.28 | 72.31 | 30.85 | 6.20 | 4.08 |
colon carcinoma cell line:CACO-2.CNhs11280.10513-107D9 | 122.41 | 66.72 | 27.28 | 6.50 | 4.38 |
colon carcinoma cell line:COLO-320.CNhs10737.10420-106C6 | 306.19 | 95.64 | 27.48 | 15.36 | 0.65 |
colon, adult, donor1.CNhs11794.10082-102B1 | 63.70 | 82.61 | 16.92 | 1.00 | 1.00 |
colon, adult, pool1.CNhs10619.10014-101C5 | 74.66 | 93.68 | 10.17 | 6.99 | 4.33 |
colon, fetal, donor1.CNhs11780.10070-101I7 | 65.99 | 119.15 | 10.39 | 4.28 | 3.06 |
cord blood derived cell line:COBL-a 24h infection(-C).CNhs11049.10452-106G2 | 128.39 | 110.01 | 44.77 | 6.82 | 2.08 |
cord blood derived cell line:COBL-a 24h infection.CNhs11050.10453-106G3 | 122.95 | 136.17 | 40.03 | 6.43 | 3.21 |
cord blood derived cell line:COBL-a untreated.CNhs11045.10449-106F8 | 109.23 | 132.51 | 34.15 | 5.64 | 0.94 |
corpus callosum, adult, pool1.CNhs10649.10042-101F6 | 67.20 | 30.40 | 9.03 | 9.10 | 2.56 |
diaphragm, fetal, donor1.CNhs11779.10069-101I6 | 71.43 | 35.31 | 11.24 | 7.22 | 3.21 |
diencephalon, adult.CNhs12610.10193-103E4 | 74.50 | 25.07 | 10.78 | 15.70 | 2.81 |
diffuse large B-cell lymphoma cell line:CTB-1.CNhs11741.10631-108I1 | 55.83 | 152.53 | 8.03 | 6.39 | 1.82 |
ductal cell carcinoma cell line:KLM-1.CNhs11100.10438-106E6 | 125.81 | 59.48 | 13.89 | 7.44 | 2.93 |
ductal cell carcinoma cell line:MIA Paca2.CNhs11259.10488-107B2 | 131.83 | 51.71 | 15.78 | 14.32 | 1.21 |
ductus deferens, adult.CNhs12846.10196-103E7 | 183.88 | 149.55 | 72.60 | 19.73 | 13.42 |
duodenum, fetal, donor1, tech_rep1.CNhs11781.10071-101I8 | 111.31 | 99.21 | 36.30 | 9.68 | 8.47 |
temporal lobe, fetal, donor1, tech_rep2.CNhs12996.10063-101H9 | 46.22 | 32.75 | 5.82 | 18.36 | 0.61 |
dura mater, adult, donor1.CNhs10648.10041-101F5 | 68.18 | 74.24 | 6.95 | 3.10 | 5.31 |
embryonic kidney cell line: HEK293/SLAM infection, 24hr.CNhs11047.10451-106G1 | 61.18 | 31.72 | 15.48 | 5.26 | 8.72 |
embryonic kidney cell line: HEK293/SLAM untreated.CNhs11046.10450-106F9 | 73.20 | 21.05 | 9.95 | 4.35 | 1.14 |
embryonic pancreas cell line:1B2C6.CNhs11731.10604-108F1 | 98.37 | 44.53 | 5.32 | 6.65 | 1.33 |
embryonic pancreas cell line:1C3D3.CNhs11732.10605-108F2 | 106.25 | 40.38 | 1.99 | 5.63 | 1.32 |
embryonic pancreas cell line:1C3IKEI.CNhs11733.10606-108F3 | 99.83 | 41.44 | 8.79 | 4.08 | 1.26 |
embryonic pancreas cell line:2C6.CNhs11814.10603-108E9 | 99.16 | 58.54 | 4.78 | 5.97 | 0.00 |
endometrial carcinoma cell line:OMC-2.CNhs11266.10497-107C2 | 194.10 | 96.20 | 44.40 | 6.55 | 3.42 |
endometrial stromal sarcoma cell line:OMC-9.CNhs11249.10448-106F7 | 120.92 | 76.96 | 14.84 | 3.05 | 1.66 |
endometrioid adenocarcinoma cell line:JHUEM-1.CNhs11748.10643-109A4 | 137.63 | 39.92 | 28.64 | 2.78 | 2.43 |
epidermoid carcinoma cell line:A431.CNhs10743.10426-106D3 | 189.03 | 155.02 | 36.36 | 6.66 | 4.70 |
epidermoid carcinoma cell line:Ca Ski.CNhs10748.10431-106D8 | 66.25 | 64.16 | 17.32 | 6.79 | 3.31 |
epididymis, adult.CNhs12847.10197-103E8 | 176.65 | 88.41 | 47.35 | 19.39 | 5.07 |
epithelioid sarcoma cell line:HS-ES-1.CNhs11247.10443-106F2 | 109.73 | 22.19 | 9.46 | 8.08 | 0.69 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1.CNhs12325.10815-111B5 | 81.37 | 63.76 | 23.80 | 5.52 | 1.74 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2.CNhs12326.10816-111B6 | 76.60 | 78.64 | 22.51 | 5.77 | 2.63 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3.CNhs12327.10817-111B7 | 82.20 | 73.08 | 23.73 | 3.70 | 2.55 |
esophagus, adult, pool1.CNhs10620.10015-101C6 | 103.58 | 92.72 | 14.65 | 6.98 | 2.33 |
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS.CNhs10728.10410-106B5 | 118.09 | 19.33 | 7.77 | 7.33 | 0.35 |
eye, fetal, donor1.CNhs11762.10054-101G9 | 76.61 | 44.74 | 12.43 | 12.43 | 1.81 |
fibrosarcoma cell line:HT-1080.CNhs11860.10758-110E2 | 219.95 | 133.62 | 33.85 | 3.97 | 3.29 |
fibrous histiocytoma cell line:GCT TIB-223.CNhs11842.10711-109H9 | 136.32 | 74.92 | 29.01 | 8.15 | 3.78 |
frontal lobe, adult, pool1.CNhs10647.10040-101F4 | 66.54 | 22.16 | 11.59 | 15.83 | 4.68 |
gall bladder carcinoma cell line:TGBC14TKB.CNhs11256.10470-106I2 | 163.29 | 46.54 | 21.71 | 7.82 | 1.96 |
gall bladder carcinoma cell line:TGBC2TKB.CNhs10733.10415-106C1 | 192.14 | 49.78 | 14.51 | 8.26 | 1.60 |
gall bladder, adult.CNhs12848.10198-103E9 | 92.00 | 84.74 | 16.86 | 7.47 | 2.13 |
gastric adenocarcinoma cell line:MKN1.CNhs11737.10614-108G2 | 89.51 | 49.95 | 9.59 | 1.60 | 3.00 |
gastric adenocarcinoma cell line:MKN45.CNhs11819.10612-108F9 | 222.19 | 64.84 | 23.05 | 2.45 | 1.30 |
gastric cancer cell line:AZ521.CNhs11286.10549-107H9 | 91.63 | 19.13 | 12.71 | 6.87 | 0.92 |
gastrointestinal carcinoma cell line:ECC12.CNhs11738.10615-108G3 | 115.48 | 56.63 | 22.14 | 15.44 | 3.26 |
giant cell carcinoma cell line:LU65.CNhs11274.10487-107B1 | 1016.45 | 273.99 | 77.36 | 17.14 | 6.19 |
giant cell carcinoma cell line:Lu99B.CNhs10751.10433-106E1 | 92.94 | 32.06 | 7.33 | 6.83 | 0.50 |
glassy cell carcinoma cell line:HOKUG.CNhs11824.10688-109F4 | 88.39 | 80.61 | 21.92 | 10.37 | 2.83 |
glioblastoma cell line:A172, tech_rep2.CNhs11248.10444-106F3 | 79.37 | 39.68 | 14.54 | 4.62 | 2.72 |
glioblastoma cell line:A172.CNhs11185.10444-106F3 | 75.31 | 48.85 | 12.55 | 6.07 | 2.09 |
glioblastoma cell line:T98G.CNhs11272.10485-107A8 | 130.76 | 64.56 | 17.95 | 6.94 | 3.88 |
glioma cell line:GI-1.CNhs10731.10413-106B8 | 87.55 | 68.77 | 21.67 | 5.78 | 2.02 |
globus pallidus - adult, donor10196.CNhs13801.10175-103C4 | 75.65 | 29.42 | 10.21 | 8.41 | 6.00 |
globus pallidus, adult, donor10252.CNhs12319.10161-103A8 | 67.49 | 28.61 | 11.64 | 12.46 | 3.15 |
granulocyte macrophage progenitor, donor1.CNhs12519.12131-128D7 | 19.16 | 175.01 | 6.39 | 0.00 | 29.38 |
granulosa cell tumor cell line:KGN.CNhs11740.10624-108H3 | 140.53 | 40.83 | 18.05 | 3.01 | 0.86 |
hairy cell leukemia cell line:Mo.CNhs11843.10712-109I1 | 70.45 | 84.65 | 14.46 | 4.73 | 1.31 |
heart - mitral valve, adult.CNhs12855.10205-103F7 | 81.27 | 40.50 | 10.89 | 10.05 | 1.95 |
heart - pulmonic valve, adult.CNhs12856.10206-103F8 | 47.89 | 24.06 | 6.19 | 15.12 | 1.37 |
heart - tricuspid valve, adult.CNhs12857.10207-103F9 | 78.97 | 66.04 | 22.97 | 2.15 | 2.15 |
heart, adult, diseased post-infarction, donor1.CNhs11757.10050-101G5 | 85.06 | 16.97 | 13.78 | 5.39 | 1.60 |
heart, adult, diseased, donor1.CNhs11758.10051-101G6 | 38.20 | 13.31 | 2.15 | 3.43 | 1.72 |
heart, adult, pool1.CNhs10621.10016-101C7 | 47.54 | 41.96 | 4.91 | 4.24 | 2.45 |
heart, fetal, pool1.CNhs10653.10046-101G1 | 42.66 | 24.99 | 4.70 | 6.05 | 0.60 |
hepatic mesenchymal tumor cell line:LI90.CNhs11868.10778-110G4 | 200.33 | 105.93 | 41.07 | 1.44 | 4.68 |
hepatoblastoma cell line:HuH-6.CNhs11742.10633-108I3 | 160.76 | 143.29 | 41.94 | 11.65 | 13.98 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1.CNhs12328.10818-111B8 | 127.23 | 36.87 | 35.22 | 4.10 | 1.02 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2.CNhs12329.10819-111B9 | 119.34 | 38.82 | 36.92 | 4.29 | 1.15 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3.CNhs12330.10820-111C1 | 122.00 | 35.66 | 32.89 | 5.12 | 0.88 |
hepatoma cell line:Li-7.CNhs11271.10484-107A7 | 135.24 | 34.74 | 16.63 | 2.17 | 0.89 |
hereditary spherocytic anemia cell line:WIL2-NS.CNhs11891.10808-111A7 | 151.82 | 164.27 | 20.66 | 11.94 | 3.89 |
hippocampus - adult, donor10196.CNhs13795.10169-103B7 | 53.28 | 23.06 | 17.50 | 15.11 | 3.98 |
hippocampus, adult, donor10252.CNhs12312.10153-102I9 | 78.45 | 22.61 | 17.43 | 17.84 | 3.41 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2.CNhs13822.13425-144D5 | 136.96 | 46.46 | 21.38 | 6.75 | 1.93 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1.CNhs13826.13433-144E4 | 130.52 | 80.32 | 28.61 | 9.22 | 2.48 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2.CNhs13839.13437-144E8 | 115.08 | 64.81 | 31.57 | 11.22 | 1.66 |
immature langerhans cells, donor1.CNhs13537.11904-125F5 | 53.99 | 112.94 | 19.12 | 2.25 | 17.10 |
immature langerhans cells, donor2.CNhs13480.11905-125F6 | 49.52 | 74.28 | 20.12 | 3.10 | 10.06 |
insula, adult, pool1.CNhs10646.10039-101F3 | 70.23 | 23.39 | 14.82 | 9.60 | 3.22 |
keratoacanthoma cell line:HKA-1.CNhs11880.10791-110H8 | 164.03 | 134.17 | 31.20 | 3.69 | 3.35 |
kidney, adult, pool1.CNhs10622.10017-101C8 | 109.38 | 55.72 | 16.31 | 9.69 | 4.33 |
kidney, fetal, pool1.CNhs10652.10045-101F9 | 101.18 | 50.15 | 13.06 | 4.67 | 1.52 |
large cell lung carcinoma cell line:IA-LM.CNhs11277.10509-107D5 | 64.52 | 52.06 | 11.93 | 1.48 | 0.84 |
large cell lung carcinoma cell line:NCI-H460.CNhs12806.10839-111E2 | 97.71 | 106.14 | 13.98 | 2.87 | 0.18 |
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF.CNhs11825.10692-109F8 | 220.13 | 167.73 | 36.66 | 16.70 | 9.40 |
left atrium, adult, donor1.CNhs11790.10079-102A7 | 49.31 | 46.46 | 0.71 | 10.01 | 5.72 |
left ventricle, adult, donor1.CNhs11789.10078-102A6 | 48.33 | 33.77 | 1.32 | 1.99 | 5.96 |
leiomyoblastoma cell line:G-402.CNhs11848.10721-110A1 | 129.68 | 18.56 | 13.73 | 2.54 | 0.51 |
leiomyoma cell line:10964C.CNhs11722.10569-108B2 | 202.00 | 103.17 | 61.36 | 10.32 | 9.23 |
leiomyoma cell line:15242A.CNhs11723.10570-108B3 | 198.77 | 89.01 | 57.90 | 6.05 | 10.37 |
leiomyoma cell line:15425.CNhs11724.10571-108B4 | 198.57 | 55.52 | 47.36 | 8.16 | 4.25 |
lens epithelial cell line:SRA 01/04.CNhs11750.10647-109A8 | 31.13 | 40.71 | 9.58 | 1.20 | 2.39 |
leukemia, chronic megakaryoblastic cell line:MEG-01.CNhs11859.10752-110D5 | 79.79 | 101.06 | 18.64 | 3.53 | 3.04 |
liposarcoma cell line:KMLS-1.CNhs11870.10782-110G8 | 115.86 | 34.59 | 12.78 | 3.41 | 2.04 |
liposarcoma cell line:SW 872.CNhs11851.10726-110A6 | 46.46 | 30.37 | 5.67 | 4.76 | 1.47 |
liver, adult, pool1.CNhs10624.10018-101C9 | 377.67 | 101.71 | 94.38 | 2.34 | 6.30 |
liver, fetal, pool1.CNhs11798.10086-102B5 | 208.04 | 78.18 | 43.73 | 1.33 | 5.30 |
locus coeruleus - adult, donor10196.CNhs13808.10182-103D2 | 53.39 | 23.66 | 12.02 | 12.54 | 4.91 |
locus coeruleus, adult, donor10252.CNhs12322.10165-103B3 | 64.53 | 18.25 | 11.77 | 12.96 | 1.85 |
lung adenocarcinoma cell line:A549.CNhs11275.10499-107C4 | 374.85 | 105.05 | 86.40 | 5.13 | 4.11 |
lung adenocarcinoma cell line:PC-14.CNhs10726.10408-106B3 | 91.63 | 93.04 | 12.69 | 12.69 | 4.93 |
lung, adult, pool1.CNhs10625.10019-101D1 | 136.47 | 188.16 | 25.95 | 3.52 | 9.29 |
lung, fetal, donor1.CNhs11680.10068-101I5 | 102.97 | 86.46 | 24.84 | 13.52 | 3.93 |
lung, right lower lobe, adult, donor1.CNhs11786.10075-102A3 | 110.60 | 105.22 | 38.94 | 5.80 | 5.80 |
lymph node, adult, donor1.CNhs11788.10077-102A5 | 81.37 | 216.82 | 11.41 | 1.49 | 12.90 |
lymphangiectasia cell line:DS-1.CNhs11852.10727-110A7 | 178.64 | 225.47 | 23.71 | 3.36 | 5.34 |
lymphoma, malignant, hairy B-cell cell line:MLMA.CNhs11935.10775-110G1 | 60.29 | 115.34 | 11.33 | 24.11 | 15.10 |
malignant trichilemmal cyst cell line:DJM-1.CNhs10730.10412-106B7 | 149.37 | 54.26 | 17.24 | 13.41 | 1.92 |
mature adipocyte, donor1.CNhs12558.12231-129F8 | 89.22 | 47.33 | 16.32 | 8.70 | 1.63 |
mature adipocyte, donor2.CNhs12559.12232-129F9 | 111.81 | 43.12 | 12.79 | 5.77 | 0.75 |
mature adipocyte, donor3.CNhs12560.12233-129G1 | 102.01 | 37.37 | 16.85 | 10.11 | 1.84 |
mature adipocyte, donor4.CNhs12562.12234-129G2 | 98.03 | 53.77 | 14.43 | 10.49 | 2.30 |
maxillary sinus tumor cell line:HSQ-89.CNhs10732.10414-106B9 | 314.27 | 99.26 | 54.18 | 10.84 | 6.91 |
medial frontal gyrus - adult, donor10196.CNhs13796.10170-103B8 | 70.89 | 16.84 | 11.52 | 4.43 | 3.54 |
medial temporal gyrus - adult, donor10196.CNhs13809.10183-103D3 | 57.11 | 20.99 | 12.08 | 14.03 | 3.66 |
medial temporal gyrus, adult, donor10252.CNhs12310.10150-102I6 | 68.35 | 20.41 | 13.27 | 14.27 | 1.88 |
medulla oblongata - adult, donor10196.CNhs13800.10174-103C3 | 86.01 | 38.42 | 16.63 | 11.47 | 3.44 |
medulla oblongata, adult, donor10252.CNhs12315.10155-103A2 | 78.87 | 25.85 | 11.31 | 16.08 | 2.11 |
medulla oblongata, adult, pool1.CNhs10645.10038-101F2 | 66.75 | 28.75 | 7.82 | 8.69 | 3.23 |
medulloblastoma cell line:D283 Med.CNhs12805.10838-111E1 | 77.89 | 41.64 | 14.11 | 3.32 | 0.83 |
medulloblastoma cell line:ONS-76.CNhs11861.10759-110E3 | 93.36 | 37.49 | 14.37 | 4.62 | 1.50 |
melanoma cell line:COLO 679.CNhs11281.10514-107E1 | 138.00 | 40.04 | 23.35 | 7.89 | 1.06 |
melanoma cell line:G-361.CNhs11254.10465-106H6 | 141.88 | 57.38 | 9.13 | 2.85 | 0.86 |
meningioma cell line:HKBMM.CNhs11945.10691-109F7 | 195.27 | 135.28 | 28.47 | 6.82 | 2.12 |
merkel cell carcinoma cell line:MKL-1.CNhs12838.10843-111E6 | 71.66 | 29.97 | 10.30 | 11.24 | 0.94 |
merkel cell carcinoma cell line:MS-1.CNhs12839.10844-111E7 | 63.91 | 17.97 | 8.55 | 8.84 | 0.14 |
mesenchymal precursor cell - adipose, donor1.CNhs12363.11747-123G1 | 191.20 | 53.73 | 34.93 | 1.19 | 1.79 |
mesenchymal precursor cell - adipose, donor2.CNhs12364.11748-123G2 | 162.90 | 72.45 | 48.38 | 3.04 | 1.40 |
mesenchymal precursor cell - adipose, donor3.CNhs12365.11749-123G3 | 144.25 | 52.71 | 21.08 | 8.88 | 0.55 |
mesenchymal precursor cell - bone marrow, donor1.CNhs12366.11750-123G4 | 79.17 | 48.49 | 16.48 | 3.79 | 0.95 |
mesenchymal precursor cell - bone marrow, donor2.CNhs12367.11751-123G5 | 94.84 | 69.18 | 19.37 | 5.28 | 1.01 |
mesenchymal precursor cell - bone marrow, donor3.CNhs13098.11840-124H4 | 141.48 | 29.36 | 24.02 | 4.45 | 0.00 |
mesenchymal precursor cell - cardiac, donor1.CNhs12368.11752-123G6 | 193.37 | 151.26 | 81.01 | 3.43 | 4.12 |
mesenchymal precursor cell - cardiac, donor2.CNhs12369.11753-123G7 | 131.42 | 61.70 | 22.68 | 0.91 | 0.60 |
mesenchymal precursor cell - cardiac, donor3.CNhs12370.11754-123G8 | 154.35 | 48.96 | 26.27 | 2.64 | 2.64 |
mesenchymal precursor cell - cardiac, donor4.CNhs12371.11755-123G9 | 136.91 | 68.01 | 50.12 | 4.29 | 5.03 |
mesenchymal precursor cell - ovarian cancer left ovary, donor1.CNhs12372.11756-123H1 | 132.85 | 64.20 | 55.59 | 3.19 | 2.55 |
mesenchymal precursor cell - ovarian cancer left ovary, donor2.CNhs13092.11833-124G6 | 187.57 | 128.64 | 50.83 | 0.90 | 2.70 |
mesenchymal precursor cell - ovarian cancer left ovary, donor3.CNhs12376.11760-123H5 | 147.50 | 59.47 | 33.07 | 2.48 | 2.17 |
mesenchymal precursor cell - ovarian cancer left ovary, donor4.CNhs13094.11836-124G9 | 206.11 | 62.62 | 35.66 | 3.32 | 1.24 |
mesenchymal precursor cell - ovarian cancer metastasis, donor1.CNhs12374.11758-123H3 | 166.42 | 74.70 | 35.62 | 2.92 | 3.46 |
mesenchymal precursor cell - ovarian cancer metastasis, donor2.CNhs13093.11835-124G8 | 174.26 | 64.17 | 29.22 | 1.57 | 1.57 |
mesenchymal precursor cell - ovarian cancer metastasis, donor3.CNhs12378.11762-123H7 | 132.23 | 58.90 | 19.38 | 2.40 | 1.20 |
mesenchymal precursor cell - ovarian cancer metastasis, donor4.CNhs13097.11838-124H2 | 118.43 | 45.70 | 36.94 | 1.90 | 4.19 |
mesenchymal precursor cell - ovarian cancer right ovary, donor1.CNhs12373.11757-123H2 | 79.34 | 34.58 | 17.90 | 5.70 | 2.44 |
mesenchymal precursor cell - ovarian cancer right ovary, donor2.CNhs12375.11759-123H4 | 137.48 | 58.01 | 31.82 | 2.00 | 1.64 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02).CNhs12377.11761-123H6 | 163.37 | 80.77 | 45.65 | 2.69 | 2.36 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G).CNhs13507.11842-124H6 | 126.68 | 85.38 | 19.03 | 1.86 | 0.93 |
mesenchymal precursor cell - ovarian cancer right ovary, donor4.CNhs13096.11837-124H1 | 120.22 | 44.19 | 22.29 | 1.19 | 1.59 |
mesenchymal stem cell line:Hu5/E18.CNhs11718.10568-108B1 | 72.81 | 16.00 | 6.80 | 4.80 | 3.20 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2.CNhs13420.13230-141I8 | 172.04 | 42.92 | 26.78 | 3.78 | 1.72 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3.CNhs13421.13231-141I9 | 187.91 | 50.85 | 21.22 | 6.06 | 0.67 |
mesodermal tumor cell line:HIRS-BM.CNhs12191.10696-109G3 | 88.33 | 47.95 | 11.36 | 3.79 | 0.00 |
mesothelioma cell line:ACC-MESO-1.CNhs11263.10493-107B7 | 277.18 | 36.60 | 19.07 | 1.54 | 1.54 |
mesothelioma cell line:ACC-MESO-4.CNhs11264.10494-107B8 | 216.80 | 103.79 | 65.83 | 2.79 | 5.79 |
mesothelioma cell line:Mero-25.CNhs13066.10850-111F4 | 199.14 | 84.56 | 36.80 | 2.87 | 4.44 |
mesothelioma cell line:Mero-41.CNhs13067.10851-111F5 | 145.09 | 48.97 | 23.80 | 1.59 | 1.13 |
mesothelioma cell line:Mero-48a.CNhs13068.10852-111F6 | 113.68 | 53.71 | 25.24 | 3.47 | 3.01 |
mesothelioma cell line:Mero-82.CNhs13069.10853-111F7 | 94.71 | 74.16 | 17.62 | 3.67 | 1.71 |
mesothelioma cell line:Mero-83.CNhs13070.10854-111F8 | 88.11 | 56.23 | 18.98 | 3.58 | 1.97 |
mesothelioma cell line:Mero-84.CNhs13072.10855-111F9 | 130.31 | 74.42 | 19.45 | 2.16 | 1.24 |
mesothelioma cell line:Mero-95.CNhs13073.10856-111G1 | 111.40 | 59.65 | 19.52 | 2.63 | 2.41 |
mesothelioma cell line:NCI-H2052.CNhs13063.10847-111F1 | 97.18 | 66.97 | 27.03 | 3.18 | 3.36 |
mesothelioma cell line:NCI-H226.CNhs13062.10846-111E9 | 107.84 | 84.88 | 27.39 | 7.14 | 1.74 |
mesothelioma cell line:NCI-H2452.CNhs13064.10848-111F2 | 147.49 | 68.42 | 15.71 | 8.28 | 3.21 |
mesothelioma cell line:NCI-H28.CNhs13061.10845-111E8 | 66.62 | 42.79 | 5.64 | 3.59 | 1.02 |
mesothelioma cell line:No36.CNhs13074.10857-111G2 | 103.97 | 56.65 | 14.85 | 4.84 | 1.04 |
mesothelioma cell line:ONE58.CNhs13075.10858-111G3 | 225.46 | 72.93 | 29.47 | 1.52 | 1.82 |
middle temporal gyrus, donor10252.CNhs12316.10156-103A3 | 64.57 | 19.77 | 13.69 | 15.21 | 3.59 |
migratory langerhans cells, donor1.CNhs13535.11901-125F2 | 88.86 | 81.06 | 11.11 | 13.06 | 3.31 |
migratory langerhans cells, donor2.CNhs13536.11902-125F3 | 68.03 | 63.78 | 10.10 | 8.64 | 2.39 |
migratory langerhans cells, donor3.CNhs13547.11903-125F4 | 57.41 | 103.37 | 4.25 | 12.92 | 1.96 |
mixed mullerian tumor cell line:HTMMT.CNhs11944.10689-109F5 | 203.45 | 38.33 | 13.10 | 2.95 | 1.31 |
mucinous adenocarcinoma cell line:JHOM-1.CNhs11752.10648-109A9 | 211.36 | 29.98 | 22.61 | 3.44 | 1.97 |
mucinous cystadenocarcinoma cell line:MCAS.CNhs11873.10784-110H1 | 196.73 | 106.50 | 35.29 | 8.24 | 5.71 |
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162.CNhs11858.10744-110C6 | 68.00 | 71.40 | 12.40 | 4.40 | 1.20 |
myelodysplastic syndrome cell line:SKM-1.CNhs11934.10772-110F7 | 36.81 | 197.70 | 10.67 | 6.40 | 4.91 |
myeloma cell line:PCM6.CNhs11258.10474-106I6 | 279.50 | 478.93 | 50.46 | 61.83 | 14.47 |
myxofibrosarcoma cell line:MFH-ino.CNhs11729.10600-108E6 | 101.59 | 52.21 | 13.05 | 2.84 | 2.27 |
myxofibrosarcoma cell line:NMFH-1.CNhs11821.10684-109E9 | 107.15 | 43.08 | 22.28 | 6.26 | 2.03 |
nasal epithelial cells, donor1, tech_rep1.CNhs12589.12226-129F3 | 374.74 | 106.87 | 33.15 | 11.05 | 1.82 |
nasal epithelial cells, donor2.CNhs12574.12227-129F4 | 227.68 | 108.86 | 34.21 | 5.60 | 3.73 |
neuroblastoma cell line:CHP-134.CNhs11276.10508-107D4 | 60.24 | 65.48 | 16.37 | 14.45 | 0.38 |
neuroblastoma cell line:NB-1.CNhs11284.10539-107G8 | 52.73 | 30.84 | 9.92 | 10.57 | 0.43 |
neuroblastoma cell line:NBsusSR.CNhs11818.10607-108F4 | 163.24 | 41.05 | 21.39 | 2.67 | 0.94 |
neuroblastoma cell line:NH-12.CNhs11811.10555-107I6 | 45.10 | 44.99 | 5.24 | 12.89 | 0.98 |
neuroectodermal tumor cell line:TASK1.CNhs11866.10774-110F9 | 170.07 | 95.39 | 11.20 | 10.18 | 0.68 |
neuroectodermal tumor cell line:FU-RPNT-1.CNhs11744.10637-108I7 | 53.99 | 105.65 | 9.35 | 6.59 | 0.64 |
neuroectodermal tumor cell line:FU-RPNT-2.CNhs11753.10663-109C6 | 58.99 | 32.97 | 6.82 | 4.96 | 0.12 |
neuroepithelioma cell line:SK-N-MC.CNhs11853.10728-110A8 | 119.55 | 68.71 | 11.73 | 2.79 | 0.56 |
neurofibroma cell line:Hs 53.T.CNhs11854.10729-110A9 | 171.40 | 27.35 | 24.49 | 1.59 | 1.59 |
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK.CNhs10747.10430-106D7 | 42.43 | 112.61 | 7.18 | 9.62 | 2.13 |
non-small cell lung cancer cell line:NCI-H1385.CNhs12193.10730-110B1 | 100.07 | 28.82 | 20.01 | 9.61 | 1.60 |
normal embryonic palatal mesenchymal cell line:HEPM.CNhs11894.10813-111B3 | 191.15 | 66.66 | 28.57 | 1.76 | 0.35 |
normal intestinal epithelial cell line:FHs 74 Int.CNhs11950.10812-111B2 | 154.35 | 44.10 | 21.74 | 3.06 | 2.14 |
nucleus accumbens, adult, pool1.CNhs10644.10037-101F1 | 74.83 | 26.40 | 12.91 | 12.33 | 1.99 |
occipital cortex - adult, donor10196.CNhs13798.10172-103C1 | 52.43 | 4.25 | 15.59 | 18.42 | 2.83 |
occipital cortex, adult, donor10252.CNhs12320.10163-103B1 | 63.85 | 19.95 | 9.10 | 14.85 | 2.39 |
occipital lobe, adult, donor1.CNhs11787.10076-102A4 | 55.59 | 21.33 | 16.00 | 9.03 | 3.69 |
occipital lobe, fetal, donor1.CNhs11784.10073-102A1 | 46.63 | 16.38 | 7.06 | 13.61 | 0.76 |
occipital pole, adult, pool1.CNhs10643.10036-101E9 | 65.42 | 19.43 | 8.64 | 5.53 | 2.90 |
olfactory region, adult.CNhs12611.10195-103E6 | 67.17 | 23.41 | 13.73 | 17.44 | 2.42 |
optic nerve, donor1.CNhs13449.10277-104E7 | 49.97 | 15.70 | 9.99 | 12.85 | 1.43 |
oral squamous cell carcinoma cell line:Ca9-22.CNhs10752.10434-106E2 | 225.54 | 99.13 | 47.80 | 20.61 | 5.30 |
oral squamous cell carcinoma cell line:HO-1-u-1.CNhs11287.10550-107I1 | 304.95 | 51.43 | 17.93 | 8.26 | 1.77 |
oral squamous cell carcinoma cell line:HSC-3.CNhs11717.10545-107H5 | 93.18 | 65.85 | 12.29 | 6.79 | 1.10 |
oral squamous cell carcinoma cell line:SAS.CNhs11810.10544-107H4 | 139.79 | 108.36 | 15.36 | 8.43 | 3.47 |
osteoclastoma cell line:Hs 706.T.CNhs11835.10704-109H2 | 145.69 | 55.30 | 9.92 | 0.76 | 1.91 |
osteosarcoma cell line:143B/TK^(-)neo^(R).CNhs11279.10510-107D6 | 89.06 | 118.74 | 23.47 | 1.38 | 4.83 |
osteosarcoma cell line:HS-Os-1.CNhs11290.10558-107I9 | 151.57 | 46.35 | 32.03 | 3.18 | 1.39 |
ovary, adult, pool1.CNhs10626.10020-101D2 | 110.48 | 73.93 | 17.37 | 10.00 | 1.73 |
pagetoid sarcoma cell line:Hs 925.T.CNhs11856.10732-110B3 | 126.87 | 72.21 | 36.11 | 1.61 | 3.83 |
pancreas, adult, donor1.CNhs11756.10049-101G4 | 503.30 | 248.52 | 181.31 | 5.47 | 9.38 |
pancreatic carcinoma cell line:NOR-P1.CNhs11832.10698-109G5 | 81.98 | 30.12 | 9.17 | 6.02 | 1.05 |
papillary adenocarcinoma cell line:8505C.CNhs11716.10437-106E5 | 79.43 | 67.80 | 11.46 | 5.90 | 4.91 |
papillotubular adenocarcinoma cell line:TGBC18TKB.CNhs10734.10417-106C3 | 88.71 | 84.28 | 14.34 | 6.06 | 1.77 |
paracentral gyrus, adult, pool1.CNhs10642.10035-101E8 | 65.44 | 19.38 | 11.75 | 8.78 | 3.11 |
parietal lobe - adult, donor10196.CNhs13797.10171-103B9 | 57.02 | 22.65 | 9.37 | 16.40 | 6.25 |
parietal lobe, adult, donor10252.CNhs12317.10157-103A4 | 68.41 | 15.91 | 11.78 | 11.16 | 3.72 |
parietal lobe, adult, pool1.CNhs10641.10034-101E7 | 65.06 | 22.01 | 12.68 | 8.43 | 3.36 |
parietal lobe, fetal, donor1.CNhs11782.10072-101I9 | 44.30 | 8.75 | 8.75 | 15.32 | 2.73 |
parotid gland, adult.CNhs12849.10199-103F1 | 273.58 | 503.85 | 133.77 | 20.29 | 48.79 |
penis, adult.CNhs12850.10200-103F2 | 71.45 | 28.78 | 4.47 | 8.44 | 0.50 |
peripheral neuroectodermal tumor cell line:KU-SN.CNhs11830.10697-109G4 | 93.92 | 31.66 | 5.63 | 4.05 | 0.35 |
pharyngeal carcinoma cell line:Detroit 562.CNhs11849.10723-110A3 | 171.33 | 87.52 | 23.89 | 6.52 | 4.34 |
pineal gland - adult, donor10196.CNhs13804.10179-103C8 | 45.00 | 19.29 | 10.71 | 28.93 | 1.61 |
pineal gland, adult, donor10252.CNhs12228.10160-103A7 | 37.66 | 11.43 | 4.37 | 34.30 | 2.35 |
pituitary gland - adult, donor10196.CNhs13805.10180-103C9 | 194.23 | 45.52 | 43.70 | 26.10 | 1.21 |
pituitary gland, adult, donor10252.CNhs12229.10162-103A9 | 123.17 | 20.26 | 23.22 | 34.38 | 1.14 |
placenta, adult, pool1.CNhs10627.10021-101D3 | 149.29 | 46.66 | 20.14 | 7.27 | 3.37 |
plasma cell leukemia cell line:ARH-77.CNhs12807.10840-111E3 | 177.00 | 173.54 | 31.80 | 15.79 | 3.57 |
pleomorphic hepatocellular carcinoma cell line:SNU-387.CNhs11933.10706-109H4 | 185.04 | 79.91 | 30.01 | 7.55 | 1.37 |
pons, adult, pool1.CNhs10640.10033-101E6 | 53.36 | 17.88 | 6.12 | 12.37 | 2.72 |
postcentral gyrus, adult, pool1.CNhs10638.10032-101E5 | 64.52 | 18.55 | 10.00 | 6.51 | 2.43 |
prostate cancer cell line:DU145.CNhs11260.10490-107B4 | 99.99 | 29.31 | 8.86 | 6.62 | 3.07 |
prostate cancer cell line:PC-3.CNhs11243.10439-106E7 | 183.98 | 56.73 | 27.92 | 16.02 | 2.34 |
prostate, adult, pool1.CNhs10628.10022-101D4 | 129.59 | 89.87 | 23.63 | 14.21 | 3.53 |
putamen, adult, donor10196.CNhs12324.10176-103C5 | 78.71 | 26.71 | 16.97 | 20.90 | 2.51 |
rectal cancer cell line:TT1TKB.CNhs11255.10469-106I1 | 172.09 | 178.53 | 71.75 | 3.92 | 5.61 |
rectum, fetal, donor1.CNhs11777.10067-101I4 | 57.53 | 54.79 | 12.78 | 5.48 | 5.48 |
renal cell carcinoma cell line:OS-RC-2.CNhs10729.10411-106B6 | 311.15 | 45.99 | 21.81 | 4.10 | 3.67 |
renal cell carcinoma cell line:TUHR10TKB.CNhs11257.10471-106I3 | 304.33 | 78.83 | 26.28 | 3.82 | 0.00 |
retina, adult, pool1.CNhs10636.10030-101E3 | 74.12 | 34.95 | 9.29 | 7.86 | 2.29 |
retinoblastoma cell line:Y79.CNhs11267.10475-106I7 | 34.60 | 28.44 | 4.42 | 4.42 | 0.32 |
rhabdomyosarcoma cell line:KYM-1.CNhs11877.10787-110H4 | 87.30 | 9.42 | 6.63 | 6.28 | 0.58 |
rhabdomyosarcoma cell line:RMS-YM.CNhs11269.10477-106I9 | 151.95 | 104.31 | 22.25 | 3.48 | 3.13 |
sacrococcigeal teratoma cell line:HTST.CNhs11829.10695-109G2 | 127.47 | 76.16 | 14.43 | 7.22 | 7.22 |
salivary acinar cells, donor1.CNhs12810.11771-123I7 | 90.76 | 110.65 | 14.30 | 5.39 | 1.86 |
salivary acinar cells, donor2.CNhs12811.11772-123I8 | 78.87 | 108.41 | 8.88 | 9.73 | 0.51 |
salivary acinar cells, donor3.CNhs12812.11773-123I9 | 53.23 | 109.22 | 11.75 | 7.60 | 3.46 |
salivary gland, adult, pool1.CNhs11677.10093-102C3 | 203.93 | 386.77 | 84.75 | 13.34 | 42.59 |
schwannoma cell line:HS-PSS, tech_rep2.CNhs11245.10442-106F1 | 124.49 | 64.14 | 10.77 | 3.90 | 2.13 |
schwannoma cell line:HS-PSS.CNhs11183.10442-106F1 | 122.54 | 75.24 | 13.89 | 5.28 | 0.60 |
seminal vesicle, adult.CNhs12851.10201-103F3 | 172.32 | 170.20 | 63.93 | 11.01 | 11.43 |
serous adenocarcinoma cell line:JHOS-2.CNhs11746.10639-108I9 | 152.59 | 67.82 | 40.78 | 8.48 | 2.75 |
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1.CNhs13508.11843-124H7 | 101.44 | 53.36 | 15.20 | 0.93 | 1.24 |
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1.CNhs13099.11841-124H5 | 130.91 | 30.58 | 22.93 | 0.00 | 0.96 |
serous cystadenocarcinoma cell line:HTOA.CNhs11827.10693-109F9 | 110.51 | 55.14 | 23.04 | 0.78 | 3.58 |
signet ring carcinoma cell line:Kato III.CNhs10753.10436-106E4 | 122.88 | 66.25 | 13.64 | 4.71 | 2.65 |
signet ring carcinoma cell line:NUGC-4.CNhs11270.10483-107A6 | 90.71 | 140.82 | 23.90 | 9.02 | 2.80 |
skeletal muscle - soleus muscle, donor1.CNhs13454.10282-104F3 | 25.25 | 4.53 | 0.65 | 7.77 | 0.65 |
skeletal muscle, adult, pool1.CNhs10629.10023-101D5 | 33.57 | 28.75 | 2.87 | 10.27 | 1.33 |
skeletal muscle, fetal, donor1.CNhs11776.10066-101I3 | 73.07 | 41.75 | 3.48 | 4.64 | 1.16 |
skin, fetal, donor1.CNhs11774.10065-101I2 | 91.31 | 42.74 | 11.66 | 8.74 | 1.46 |
small cell cervical cancer cell line:HCSC-1.CNhs11885.10800-110I8 | 76.73 | 21.05 | 8.19 | 3.74 | 1.40 |
small cell gastrointestinal carcinoma cell line:ECC10.CNhs11736.10610-108F7 | 43.77 | 31.63 | 8.55 | 22.88 | 3.18 |
small cell lung carcinoma cell line:DMS 144.CNhs12808.10841-111E4 | 85.03 | 10.82 | 6.54 | 2.02 | 1.31 |
small cell lung carcinoma cell line:LK-2.CNhs11285.10541-107H1 | 86.86 | 58.39 | 14.12 | 15.81 | 2.71 |
small cell lung carcinoma cell line:NCI-H82.CNhs12809.10842-111E5 | 216.58 | 105.21 | 24.74 | 1.87 | 0.66 |
small cell lung carcinoma cell line:WA-hT.CNhs11812.10562-108A4 | 132.70 | 55.86 | 26.87 | 45.74 | 6.49 |
small intestine, adult, pool1.CNhs10630.10024-101D6 | 97.32 | 111.98 | 17.67 | 5.94 | 6.64 |
small intestine, fetal, donor1.CNhs11773.10064-101I1 | 105.56 | 89.61 | 14.42 | 5.90 | 2.19 |
small-cell gastrointestinal carcinoma cell line:ECC4.CNhs11734.10609-108F6 | 141.57 | 60.67 | 21.16 | 11.29 | 7.05 |
smooth muscle, adult, pool1.CNhs11755.10048-101G3 | 65.70 | 26.72 | 4.17 | 10.54 | 0.98 |
somatostatinoma cell line:QGP-1.CNhs11869.10781-110G7 | 115.95 | 166.86 | 43.36 | 6.83 | 8.72 |
spinal cord - adult, donor10196.CNhs13807.10181-103D1 | 64.39 | 32.78 | 10.60 | 13.15 | 4.91 |
spinal cord, adult, donor10252.CNhs12227.10159-103A6 | 62.68 | 47.23 | 10.69 | 13.66 | 6.54 |
spinal cord, fetal, donor1.CNhs11764.10056-101H2 | 69.32 | 28.74 | 10.57 | 10.14 | 2.11 |
spindle cell sarcoma cell line:Hs 132.T.CNhs11857.10737-110B8 | 167.38 | 70.52 | 28.55 | 0.51 | 3.06 |
spleen, adult, pool1.CNhs10631.10025-101D7 | 74.53 | 184.58 | 14.57 | 4.42 | 13.16 |
spleen, fetal, pool1.CNhs10651.10044-101F8 | 67.49 | 94.17 | 10.89 | 2.00 | 4.83 |
splenic lymphoma with villous lymphocytes cell line:SLVL.CNhs10741.10424-106D1 | 62.96 | 124.63 | 12.39 | 23.29 | 2.30 |
squamous cell carcinoma cell line:EC-GI-10.CNhs11252.10463-106H4 | 166.41 | 78.92 | 20.18 | 11.78 | 2.32 |
squamous cell carcinoma cell line:T3M-5.CNhs11739.10616-108G4 | 189.50 | 155.63 | 58.23 | 33.53 | 5.65 |
squamous cell lung carcinoma cell line:EBC-1.CNhs11273.10486-107A9 | 259.42 | 98.78 | 44.69 | 43.81 | 7.78 |
stomach, fetal, donor1.CNhs11771.10062-101H8 | 79.61 | 69.38 | 17.53 | 4.38 | 2.19 |
submaxillary gland, adult.CNhs12852.10202-103F4 | 172.02 | 355.97 | 66.52 | 22.48 | 33.49 |
substantia nigra, adult, donor10252.CNhs12318.10158-103A5 | 67.66 | 26.37 | 10.61 | 12.61 | 2.44 |
synovial sarcoma cell line:HS-SY-II.CNhs11244.10441-106E9 | 79.04 | 27.29 | 13.41 | 1.74 | 0.00 |
temporal lobe, adult, pool1.CNhs10637.10031-101E4 | 59.97 | 22.85 | 10.61 | 5.17 | 3.26 |
temporal lobe, fetal, donor1, tech_rep1.CNhs11772.10063-101H9 | 45.82 | 30.11 | 8.73 | 10.47 | 1.31 |
duodenum, fetal, donor1, tech_rep2.CNhs12997.10071-101I8 | 117.44 | 87.29 | 15.34 | 10.05 | 2.65 |
tenocyte, donor1.CNhs12639.11763-123H8 | 175.95 | 54.68 | 20.09 | 2.23 | 1.86 |
tenocyte, donor2.CNhs12640.11765-123I1 | 112.77 | 61.47 | 14.79 | 3.70 | 0.00 |
tenocyte, donor3.CNhs12641.11768-123I4 | 176.51 | 61.43 | 28.55 | 3.46 | 2.60 |
teratocarcinoma cell line:PA-1.CNhs11890.10807-111A6 | 95.63 | 58.79 | 10.72 | 4.04 | 1.89 |
teratocarcinoma cell line:NCC-IT-A3.CNhs11878.10790-110H7 | 109.37 | 31.80 | 12.02 | 7.54 | 0.98 |
teratocarcinoma cell line:NCR-G1.CNhs11884.10798-110I6 | 106.17 | 31.93 | 10.14 | 2.91 | 0.25 |
testicular germ cell embryonal carcinoma cell line:ITO-II.CNhs11876.10786-110H3 | 188.07 | 74.55 | 39.16 | 1.43 | 2.14 |
testicular germ cell embryonal carcinoma cell line:NEC14.CNhs12351.10591-108D6 | 116.77 | 59.32 | 14.70 | 5.61 | 1.07 |
testicular germ cell embryonal carcinoma cell line:NEC15.CNhs12362.10593-108D8 | 61.66 | 83.81 | 14.34 | 5.24 | 1.47 |
testicular germ cell embryonal carcinoma cell line:NEC8.CNhs11726.10590-108D5 | 97.53 | 23.82 | 9.53 | 5.01 | 0.75 |
testis, adult, pool1.CNhs10632.10026-101D8 | 92.22 | 51.91 | 15.38 | 6.82 | 5.68 |
testis, adult, pool2.CNhs12998.10096-102C6 | 66.72 | 19.83 | 12.86 | 6.97 | 4.29 |
thalamus - adult, donor10196.CNhs13794.10168-103B6 | 77.94 | 17.41 | 9.95 | 13.27 | 0.00 |
thalamus, adult, donor10252.CNhs12314.10154-103A1 | 69.71 | 24.82 | 12.52 | 13.76 | 1.97 |
throat, adult.CNhs12858.10209-103G2 | 69.09 | 72.50 | 14.71 | 15.35 | 4.90 |
throat, fetal, donor1.CNhs11770.10061-101H7 | 75.23 | 37.85 | 9.52 | 10.24 | 2.38 |
thymus, adult, pool1.CNhs10633.10027-101D9 | 90.17 | 123.11 | 17.12 | 7.04 | 1.49 |
thymus, fetal, pool1.CNhs10650.10043-101F7 | 71.20 | 85.29 | 12.60 | 8.50 | 1.80 |
thyroid carcinoma cell line:TCO-1.CNhs11872.10783-110G9 | 135.68 | 101.70 | 19.06 | 5.05 | 2.92 |
thyroid, adult, pool1.CNhs10634.10028-101E1 | 209.27 | 93.75 | 35.32 | 9.61 | 4.39 |
thyroid, fetal, donor1.CNhs11769.10060-101H6 | 124.91 | 38.00 | 19.20 | 13.74 | 4.85 |
tongue, adult.CNhs12853.10203-103F5 | 62.27 | 38.75 | 12.63 | 11.10 | 2.18 |
tongue, fetal, donor1.CNhs11768.10059-101H5 | 58.86 | 40.04 | 7.87 | 5.82 | 5.48 |
tonsil, adult, pool1.CNhs10654.10047-101G2 | 89.85 | 133.16 | 14.01 | 4.51 | 3.03 |
trachea, adult, pool1.CNhs10635.10029-101E2 | 150.19 | 165.89 | 37.30 | 6.81 | 10.26 |
trachea, fetal, donor1.CNhs11766.10058-101H4 | 109.45 | 95.47 | 31.60 | 5.32 | 4.99 |
transitional-cell carcinoma cell line:5637.CNhs10735.10418-106C4 | 111.20 | 73.34 | 29.71 | 6.11 | 5.54 |
transitional-cell carcinoma cell line:JMSU1.CNhs11261.10492-107B6 | 138.85 | 79.94 | 21.35 | 9.93 | 0.75 |
tridermal teratoma cell line:HGRT.CNhs11828.10694-109G1 | 88.81 | 55.99 | 13.52 | 0.00 | 3.86 |
tubular adenocarcinoma cell line:SUIT-2.CNhs11883.10797-110I5 | 93.87 | 66.02 | 10.06 | 1.89 | 1.98 |
umbilical cord, fetal, donor1.CNhs11765.10057-101H3 | 84.47 | 28.16 | 2.35 | 7.04 | 2.35 |
uterus, adult, pool1.CNhs11676.10100-102D1 | 82.51 | 42.54 | 14.06 | 9.05 | 0.12 |
uterus, fetal, donor1.CNhs11763.10055-101H1 | 87.08 | 47.20 | 10.99 | 6.10 | 1.63 |
vagina, adult.CNhs12854.10204-103F6 | 100.53 | 103.86 | 27.96 | 0.67 | 2.00 |
vein, adult.CNhs12844.10191-103E2 | 79.91 | 120.56 | 10.67 | 8.05 | 1.81 |
xeroderma pigentosum b cell line:XPL 17.CNhs11813.10563-108A5 | 102.90 | 176.95 | 13.46 | 15.39 | 2.56 |